hg_52847.1

Basic information about the TSS

---

TSS ID: hg_52847.1 Species: human Chr: chr4		Start: 82429386 End: 82429392 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000507721.5 Distance: -5 GeneID: 9987 HGNC/MGI_ID: HGNC:5037 UniProt_ID: O14979

Gene_name: heterogeneous nuclear ribonucleoprotein D like Gene_symbol: HNRNPDL Gene_synonyms: JKTBP laAUF1 Gene_source: HGNC:5037

TATA-Box annotation

---

Distance to TSS:	836
Nearest PromoterID:	NM_001207000
Entrez ID:	9987
Nearest Unigene:	Hs.527105
Nearest Refseq:	NM_005463
Nearest Ensembl:	ENSG00000152795
Gene Name:	heterogeneous nuclear ribonucleoprotein D like
Gene Alias:	HNRNP|HNRPDL|JKTBP|JKTBP2|LGMD1G|LGMDD3|laAUF1
Gene Description:	heterogeneous nuclear ribonucleoprotein D like
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.636816
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	-83(GGCTATAAAGGG,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HNRNPDL p2@HNRNPDL p3@HNRNPDL p4@HNRNPDL p5@HNRNPDL p6@HNRNPDL p7@HNRNPDL p8@HNRNPDL p9@HNRNPDL p10@HNRNPDL
Sample		p1@HNRNPDL	p2@HNRNPDL	p3@HNRNPDL	p4@HNRNPDL	p5@HNRNPDL	p6@HNRNPDL	p7@HNRNPDL	p8@HNRNPDL	p9@HNRNPDL	p10@HNRNPDL
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	173.96	31.56	7.99	20.84	6.23	0.97	1.17	0.39	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	179.25	25.69	8.09	23.47	7.28	0.20	1.42	0.20	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	196.38	28.55	9.26	20.45	4.05	2.12	2.12	0.96	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	142.00	19.13	6.45	14.76	5.41	1.46	0.62	0.21	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	153.88	20.47	5.62	18.22	5.85	0.67	1.35	0.45	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	164.93	23.26	8.33	15.12	4.07	0.58	1.16	0.39	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	220.72	27.89	2.61	15.25	5.01	1.53	2.18	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	162.77	17.92	6.30	14.29	3.39	0.24	2.42	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	145.33	20.30	5.56	12.82	7.27	0.21	1.07	0.43	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	171.57	27.24	11.01	8.11	13.33	0.58	1.74	0.58	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	135.42	24.25	12.94	12.94	10.11	0.40	1.62	1.21	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	141.48	30.90	14.23	7.32	14.23	1.22	0.81	2.03	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	86.24	8.54	16.76	7.41	4.67	1.29	1.45	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	89.31	11.88	7.52	7.22	5.56	1.35	1.50	0.00	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	93.09	10.10	11.42	5.71	2.85	1.76	1.32	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	95.06	7.04	10.56	6.04	6.54	0.75	1.76	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	78.84	7.86	5.24	3.28	3.71	1.31	1.97	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	109.67	4.22	7.17	5.06	4.22	0.42	5.06	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	109.83	14.93	7.46	3.73	6.40	2.13	5.33	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	95.08	9.93	9.93	6.32	5.72	1.20	1.50	0.15	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	100.64	9.09	8.29	5.21	3.74	0.27	1.60	0.13	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	99.95	8.63	9.15	7.94	5.87	0.52	2.24	0.35	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	98.36	10.47	9.31	6.33	4.01	1.68	1.29	0.00	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	94.40	7.52	8.49	3.15	4.13	0.24	2.43	0.49	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	105.26	11.61	9.29	5.68	4.39	1.55	4.64	0.26	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	112.36	10.44	8.23	6.96	6.65	0.63	3.17	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	135.17	10.99	12.09	4.40	4.95	1.10	10.44	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	86.99	10.84	8.25	5.89	3.77	0.24	0.94	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	86.90	7.43	6.46	5.81	3.39	0.16	1.29	0.16	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	89.22	8.51	8.87	3.98	2.71	0.36	1.09	0.36	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	77.04	6.28	4.61	3.14	2.09	0.21	1.47	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	76.98	8.21	4.69	4.88	3.32	0.00	1.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	75.97	6.33	6.75	2.74	3.17	1.06	1.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	107.38	8.25	7.09	4.12	2.31	0.49	2.14	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	76.67	8.98	4.30	5.24	2.43	0.37	0.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	82.21	7.28	5.37	3.45	3.83	0.77	0.57	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	70.92	7.56	3.27	4.09	3.07	0.61	1.23	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	75.56	4.63	4.63	3.22	2.22	0.81	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	90.48	7.83	6.21	2.97	2.97	0.81	1.08	0.54	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	86.18	7.20	7.44	5.76	2.64	0.48	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	78.81	6.35	5.18	4.00	2.59	1.18	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	97.94	8.34	5.56	3.51	3.07	0.73	1.32	0.44	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	77.61	8.22	7.38	4.64	3.80	0.63	0.42	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	87.41	9.09	7.52	4.55	2.62	0.52	0.17	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	96.37	7.83	6.63	4.02	3.01	1.00	1.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	92.83	10.47	5.58	3.95	2.79	0.93	1.16	0.23	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	78.69	5.76	6.96	3.36	3.60	0.24	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	98.65	8.05	8.05	4.47	3.87	0.30	0.89	0.00	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	83.54	9.81	6.46	4.55	5.27	0.48	0.24	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	87.35	9.10	7.68	4.04	7.28	1.21	0.40	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	101.86	10.45	8.20	4.30	5.94	0.82	0.61	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	105.18	10.67	9.12	3.56	9.12	0.89	1.56	0.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1357.24	223.87	13.99	0.00	0.00	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	90.49	7.10	4.61	4.26	3.55	0.35	1.42	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	90.14	5.63	4.97	5.96	4.64	0.33	0.33	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	212.25	33.56	17.62	1.68	2.52	10.91	1.68	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	121.24	17.45	6.89	4.59	2.76	0.46	1.38	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	95.29	10.70	6.16	5.83	3.89	0.65	2.27	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	75.47	4.82	2.89	3.53	5.14	0.00	0.64	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	114.10	15.09	7.54	3.46	5.03	0.63	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	74.74	7.05	2.82	2.12	4.94	0.00	1.41	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	75.15	2.24	2.80	2.80	5.61	0.56	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	87.58	13.53	18.31	1.59	2.39	0.00	0.80	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	79.51	12.91	6.80	2.38	4.08	0.34	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	76.03	8.12	4.87	3.57	4.87	0.97	0.65	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	73.84	7.10	4.61	3.55	3.55	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1082.98	242.46	16.16	0.00	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1002.98	181.64	0.00	0.00	15.79	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	82.39	8.78	4.39	3.41	4.39	0.00	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	78.84	9.42	3.97	5.95	1.98	0.50	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	98.98	9.38	3.75	7.04	1.88	0.00	1.41	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	111.28	12.92	5.96	4.64	3.31	0.00	0.66	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	89.40	11.45	3.40	4.95	3.71	1.24	0.31	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	93.86	11.62	2.75	6.73	4.28	0.61	0.31	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	116.57	10.93	0.95	1.43	2.06	0.32	1.11	0.00	0.00	0.00
Adipocyte - breast, donor2	11327-117E4	93.53	6.90	1.93	1.12	1.93	0.48	0.64	0.16	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	129.52	8.02	1.15	1.65	2.80	0.13	0.76	0.25	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	75.50	6.73	2.24	1.49	0.00	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	77.70	6.70	1.67	1.34	0.67	0.00	0.33	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	75.92	6.38	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	46.18	3.30	4.40	3.30	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	53.29	8.13	0.00	1.35	2.71	0.00	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	40.84	2.26	1.22	1.74	1.04	0.35	0.87	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	133.58	9.58	7.82	5.67	4.30	3.52	0.78	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	98.58	9.78	7.98	2.83	2.32	1.03	0.51	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	166.15	13.66	5.58	3.90	4.46	1.67	1.95	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	114.04	10.58	5.29	4.11	4.11	1.76	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	118.88	8.53	4.26	3.70	2.57	3.46	1.05	0.08	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	127.17	12.26	1.94	3.87	2.58	1.94	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	109.84	6.40	2.13	1.07	2.13	1.07	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	124.64	8.35	1.67	0.56	2.78	0.00	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	87.34	6.24	1.66	1.25	2.91	0.42	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	96.95	6.28	2.51	2.51	2.01	0.00	0.50	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	87.37	3.60	3.60	2.95	1.64	0.33	0.65	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	84.64	6.70	2.44	1.22	1.83	1.52	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	63.43	5.30	2.43	1.10	1.77	0.00	0.22	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	26.89	2.15	1.43	1.79	0.72	0.00	0.00	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	21.56	3.59	2.40	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	73.94	5.94	2.52	1.98	2.88	0.18	1.08	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	53.55	5.02	1.67	1.67	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	56.70	5.55	3.08	1.64	2.26	0.62	0.82	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	140.29	10.98	1.14	0.80	1.37	0.11	1.72	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	63.68	7.10	1.71	1.22	1.22	0.00	0.24	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	119.96	9.88	1.35	0.90	0.90	0.00	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	142.40	12.59	1.74	3.47	3.47	0.00	1.74	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	100.59	4.28	0.00	2.14	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	133.32	11.36	1.49	1.49	2.09	0.00	1.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	151.76	11.38	1.26	0.00	3.79	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	100.99	5.94	1.32	1.32	1.32	0.00	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	110.14	10.72	0.97	1.95	3.90	0.00	1.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	127.19	9.22	2.43	3.40	0.97	0.00	2.43	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	113.43	5.94	1.78	1.19	1.78	0.59	1.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	122.78	6.40	1.13	3.01	0.38	0.38	0.75	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	121.91	6.53	0.73	2.18	3.63	0.00	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	94.03	5.02	2.51	1.25	0.00	0.00	3.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	120.09	11.53	1.81	2.97	2.97	0.00	0.49	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	101.00	8.19	0.00	1.36	4.09	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	97.56	6.79	1.51	2.87	2.71	0.00	1.36	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	140.38	13.39	1.61	2.68	2.68	0.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	109.58	10.01	2.65	2.08	2.83	0.00	0.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	125.36	16.84	2.14	1.60	3.74	0.00	1.60	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	116.08	7.80	2.93	0.98	3.90	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	108.47	6.80	1.82	2.32	2.32	0.17	0.17	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	112.87	8.41	2.40	1.20	2.40	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	113.28	0.00	0.00	3.54	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	102.06	8.58	1.54	2.57	2.06	0.17	1.20	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	113.26	4.19	0.00	0.00	0.00	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	131.06	13.59	1.94	2.43	0.49	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	120.67	7.21	1.90	2.28	1.14	0.00	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	79.95	7.27	1.21	2.42	1.21	0.00	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	127.69	8.55	0.00	0.00	3.99	0.00	1.14	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	105.39	7.48	0.86	1.07	2.35	0.43	0.64	0.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	89.30	6.19	1.29	2.84	2.84	0.26	1.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	103.69	10.79	2.82	1.41	0.00	0.00	1.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	91.96	7.07	1.61	1.61	1.93	0.32	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	68.49	4.28	0.71	0.00	2.14	0.00	2.14	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	114.65	8.19	1.75	1.17	1.75	0.00	1.75	0.00	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	96.34	6.92	1.81	0.90	1.51	0.00	0.60	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	103.36	4.75	0.00	3.56	1.19	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	129.68	16.27	1.53	0.51	2.54	0.51	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	116.14	10.44	0.76	1.53	3.31	0.00	1.02	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	78.79	3.81	0.64	1.27	2.54	0.00	1.27	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	106.59	6.90	1.29	0.86	0.43	0.43	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	92.08	5.93	0.64	1.69	0.85	0.00	0.64	0.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	96.85	6.67	2.32	0.58	1.74	0.58	0.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	111.48	9.45	1.89	3.78	0.00	0.00	3.78	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	100.36	7.29	1.19	4.24	1.70	0.17	0.51	0.00	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	71.81	9.27	2.32	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	118.30	6.34	2.11	4.23	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	107.85	7.72	1.93	2.14	2.79	0.00	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	126.35	6.02	1.20	1.20	0.00	0.00	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	137.78	10.21	2.92	1.46	0.73	0.73	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	103.22	8.51	1.15	1.38	0.69	0.00	0.46	0.00	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	94.36	10.20	0.00	2.55	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	99.91	7.37	0.51	1.02	2.54	0.00	1.27	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	112.72	9.29	2.48	1.65	2.27	0.21	1.24	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	107.41	9.18	1.22	1.22	3.06	0.31	1.84	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	117.11	8.13	1.91	1.43	0.00	0.00	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	95.79	5.77	1.33	2.22	2.22	0.00	0.67	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	85.44	4.58	0.00	0.00	1.53	0.00	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	109.12	9.42	2.22	2.77	1.66	0.00	1.66	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	79.97	6.88	1.32	1.32	1.32	0.00	0.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	93.77	5.82	1.09	1.45	1.82	0.00	0.73	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	88.92	9.33	6.88	1.97	2.95	0.12	0.25	0.12	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	60.76	6.33	5.65	4.28	1.88	0.17	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	40.48	3.99	4.82	3.78	2.10	0.42	0.63	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	337.78	35.90	11.50	4.18	2.79	1.05	1.39	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	324.84	33.81	10.03	7.28	2.59	0.32	0.49	0.32	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	303.09	38.78	15.96	7.76	4.47	0.60	0.45	0.45	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	462.99	29.47	29.36	11.81	14.22	1.61	0.46	0.57	0.46	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	471.81	40.34	26.94	16.16	13.28	1.63	0.00	0.38	0.88	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	445.51	33.34	27.65	12.40	12.18	1.37	0.23	0.68	1.48	0.57
Basophils, donor1	12241-129G9	179.15	19.09	12.82	4.71	15.43	0.26	0.78	1.05	0.26	0.26
Basophils, donor2	12242-129H1	492.49	45.10	16.96	3.97	51.23	3.97	2.53	3.61	0.00	0.72
Basophils, donor3	12243-129H2	247.25	12.35	16.02	6.61	22.49	0.88	1.91	1.62	0.29	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	20.27	0.86	3.45	0.22	0.22	0.00	0.65	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	14.63	2.29	2.74	0.46	0.91	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	78.91	0.00	0.00	0.00	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	75.32	5.65	2.51	3.14	1.26	0.63	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	49.08	2.70	2.08	1.25	0.62	0.00	0.00	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	42.37	2.76	0.92	1.15	1.84	0.00	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	69.28	7.20	4.50	0.36	1.62	0.00	0.54	0.00	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	515.38	29.27	18.03	17.11	21.33	1.85	2.89	1.65	0.93	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	439.96	23.76	10.71	20.03	10.71	2.33	2.56	1.40	1.16	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	593.50	62.04	41.89	22.06	27.50	1.92	6.40	1.28	1.60	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1013.51	72.39	20.68	20.68	41.37	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	214.71	11.83	14.09	9.02	12.40	0.56	2.82	2.82	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	288.05	18.37	13.73	6.68	18.56	0.74	1.86	2.04	0.56	0.37
CD14+ Monocytes, donor3	11381-118B4	227.00	14.05	19.10	5.27	20.20	0.66	0.66	1.32	0.00	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	161.90	11.32	7.64	3.40	5.38	2.83	2.55	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	164.14	11.75	4.17	3.41	12.13	5.31	0.76	1.52	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	165.03	12.82	6.57	1.97	6.57	4.60	1.97	0.33	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	127.93	9.83	3.76	1.30	7.08	0.58	1.59	0.72	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	121.90	9.35	2.11	1.81	6.34	0.30	1.21	0.91	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	118.45	7.58	4.50	0.71	7.82	1.18	1.42	1.42	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	106.30	6.19	2.51	1.34	2.51	0.50	0.33	0.33	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	115.10	6.62	3.04	1.10	4.42	0.28	2.21	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	150.24	12.15	3.72	1.49	5.70	0.25	0.74	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	84.78	6.85	1.57	0.78	0.20	0.00	3.13	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	106.30	6.77	2.67	0.53	2.85	0.00	2.49	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	162.79	10.01	4.57	0.44	2.39	0.22	4.57	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	165.76	8.66	3.28	2.34	3.28	0.00	2.11	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	271.93	10.56	6.86	1.58	2.11	2.11	2.64	0.53	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	265.14	14.42	9.98	3.33	2.22	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	127.03	8.78	2.38	1.04	4.31	0.59	2.23	0.30	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	98.38	7.58	2.00	1.00	3.79	0.40	1.20	0.60	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	122.21	8.95	1.46	0.62	3.54	0.42	4.16	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	114.39	9.38	3.43	0.92	1.37	0.00	2.52	0.46	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	108.13	7.69	2.94	1.36	2.71	0.45	3.39	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	120.46	6.11	1.31	0.44	5.24	0.00	1.75	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	103.02	8.61	2.69	1.08	5.38	0.00	0.54	0.81	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	143.93	7.15	4.01	1.57	4.19	0.70	2.62	0.17	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	130.45	11.36	3.37	0.84	5.47	0.00	2.52	0.42	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	86.71	6.06	2.39	0.92	1.84	0.18	2.20	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	81.37	5.28	1.06	1.06	3.17	0.00	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	99.15	6.58	1.75	1.75	2.63	0.00	1.75	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	117.18	7.32	2.79	1.05	0.87	0.17	1.74	0.17	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	139.75	7.43	4.09	1.49	2.23	0.00	2.97	0.37	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	196.15	12.07	4.53	1.29	2.59	0.22	4.31	0.00	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	115.89	8.60	1.23	0.82	3.69	0.00	1.23	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	91.79	5.10	2.32	0.46	2.09	0.00	1.62	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	121.56	8.12	2.55	0.46	1.62	0.23	3.71	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	398.22	50.79	14.82	5.23	19.83	0.44	2.18	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	456.91	38.11	21.02	3.23	18.48	1.15	2.77	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	372.58	35.96	17.76	2.82	16.68	0.65	2.17	0.65	0.65	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	446.45	33.17	16.97	5.14	22.42	0.78	4.20	0.78	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	421.07	31.96	15.54	5.06	17.46	0.17	1.75	1.05	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	393.99	47.72	19.18	4.91	17.84	0.67	2.68	0.67	0.45	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	380.21	42.10	13.27	4.85	18.88	0.51	2.30	0.26	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	462.40	46.11	28.76	5.49	20.42	0.22	3.95	0.00	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	381.51	46.53	21.69	3.37	19.79	1.05	1.68	1.05	1.05	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	593.43	42.68	16.26	8.13	24.39	2.03	4.06	0.00	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	593.23	48.14	21.02	6.78	26.44	0.00	2.03	0.68	0.68	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	550.94	43.50	13.46	10.36	25.89	2.07	3.11	0.00	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	530.91	45.31	36.25	6.93	28.25	1.60	8.53	0.53	0.53	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	718.87	58.43	27.34	10.19	27.34	1.61	5.90	3.22	0.54	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	588.93	54.75	16.14	7.02	37.20	1.40	4.21	4.91	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	578.07	36.86	21.18	3.92	28.24	0.78	3.92	2.35	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	584.00	56.69	29.00	3.95	31.64	1.32	5.27	1.32	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	649.30	32.05	55.89	29.59	58.35	0.82	0.00	0.00	1.64	2.47
CD19+ B Cells, donor2	11624-122B4	528.84	24.66	39.90	19.59	49.33	2.18	3.63	0.00	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	530.07	28.78	32.31	26.76	35.84	2.02	1.51	7.57	0.00	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	352.34	63.84	31.11	4.85	2.02	2.83	1.62	0.81	0.81	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	255.67	46.74	22.77	5.19	1.20	1.20	1.20	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	341.38	17.07	11.04	11.04	10.04	0.00	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	493.83	29.78	10.67	5.62	19.10	1.12	0.56	1.12	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	408.45	39.45	34.57	12.78	14.28	2.25	3.01	0.75	3.01	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	470.58	57.72	34.72	16.01	16.01	0.90	3.16	0.45	1.35	0.68
CD4+ T Cells, donor1	11225-116C1	691.62	36.78	53.56	7.86	60.70	1.79	5.00	3.21	1.43	5.36
CD4+ T Cells, donor2	11306-117C1	650.33	51.44	47.15	4.29	72.87	0.61	3.67	3.67	0.61	4.29
CD4+ T Cells, donor3	11382-118B5	536.48	41.78	41.48	7.93	64.66	1.83	1.22	3.96	0.91	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	308.84	28.59	13.78	0.77	25.01	0.77	5.10	1.28	0.51	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	321.40	21.79	16.84	1.12	31.22	0.45	6.06	3.59	0.67	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	263.60	20.41	18.68	2.59	31.91	0.00	3.74	2.01	0.00	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	964.30	90.55	50.25	3.32	75.38	1.42	7.59	4.27	0.00	12.33
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1019.77	104.65	69.53	5.62	69.53	2.11	8.43	9.13	0.70	9.83
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	705.39	115.37	65.92	3.30	72.52	0.00	6.59	6.59	3.30	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	244.66	22.40	9.39	1.30	19.51	0.87	2.02	2.75	0.14	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	224.54	17.29	12.37	2.20	17.45	0.00	3.22	2.54	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	208.28	18.70	12.25	1.93	17.09	0.48	2.74	0.97	0.81	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	572.03	37.21	30.04	3.59	42.59	0.90	4.93	3.59	1.79	7.62
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	637.98	64.64	27.25	2.80	52.76	1.40	3.49	3.84	1.05	4.54
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	522.26	58.08	27.28	2.20	52.80	0.44	5.72	5.72	0.00	9.24
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	312.44	37.95	18.13	1.26	23.61	1.69	1.69	1.69	0.42	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	202.58	24.72	13.71	1.45	18.08	0.42	4.57	1.25	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	210.83	28.40	17.04	1.00	23.39	0.67	1.67	0.33	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	814.99	76.14	52.76	3.54	62.82	1.36	6.25	3.26	1.90	8.70
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1013.48	110.41	65.39	2.68	83.61	2.68	4.82	8.58	0.00	15.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	641.98	57.38	69.94	3.59	73.52	1.79	5.38	7.17	1.79	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	356.02	39.50	18.17	3.52	27.81	1.48	3.52	1.67	0.00	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	253.66	20.15	14.73	1.52	29.68	0.43	2.60	1.30	0.00	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	248.40	19.96	14.71	3.78	33.20	0.84	1.26	2.94	1.26	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	703.80	61.68	30.34	1.01	54.10	0.51	6.07	2.53	0.00	3.54
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	733.49	74.09	40.29	1.73	55.02	0.43	6.93	3.03	0.00	5.20
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	765.29	100.67	46.63	1.31	67.12	1.31	7.41	7.41	0.44	4.79
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	660.16	66.81	33.16	1.48	58.89	0.99	7.42	3.96	0.99	7.42
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	585.30	69.24	27.70	2.77	37.85	0.00	4.62	3.69	0.00	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	584.85	73.98	26.52	0.00	34.90	2.79	6.98	2.79	1.40	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	756.85	80.86	31.57	2.77	30.19	1.11	2.77	2.49	0.28	4.43
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	738.14	67.24	30.67	2.21	35.83	0.49	1.96	2.21	0.25	6.87
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	608.30	66.22	20.02	1.54	61.60	1.54	1.54	0.00	0.00	7.70
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	651.42	66.61	29.37	2.15	47.27	0.72	11.46	3.22	0.00	6.09
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	674.49	73.40	20.77	1.38	47.09	0.00	9.69	1.38	2.77	2.77
CD8+ T Cells, donor1	11226-116C2	570.65	49.76	38.96	5.24	89.38	1.96	3.93	5.24	0.33	5.24
CD8+ T Cells, donor2	11307-117C2	455.77	41.30	30.41	9.01	108.88	0.75	4.13	5.26	1.13	4.51
CD8+ T Cells, donor3	11383-118B6	585.02	50.50	46.46	8.33	87.87	2.78	4.04	6.06	1.26	6.31
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	145.66	18.81	8.49	11.47	5.05	0.00	2.29	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	142.59	17.49	5.75	14.38	2.64	0.48	3.12	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	156.77	15.87	10.12	13.68	4.92	0.82	3.01	0.00	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	138.70	17.71	4.20	7.51	2.10	0.90	4.50	0.90	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	127.67	13.92	7.92	10.32	4.56	0.72	3.12	0.00	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	128.02	13.64	6.14	15.23	4.32	0.00	2.96	0.45	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	166.01	17.60	5.21	12.82	6.52	0.22	2.82	0.22	0.43	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	175.82	22.11	6.05	10.79	5.53	0.79	3.16	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	157.13	22.51	8.44	15.71	4.46	0.70	1.88	0.70	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	208.60	28.38	13.58	19.62	6.34	0.60	3.62	1.21	0.30	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	221.95	26.73	11.04	13.36	7.26	0.29	4.94	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	151.87	28.51	11.99	15.99	5.60	0.27	3.46	0.80	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	154.53	13.57	9.63	13.57	7.44	0.44	3.06	2.63	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	134.35	14.57	5.92	13.21	5.01	1.37	4.55	2.28	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	145.45	8.95	5.97	7.46	2.98	0.00	2.98	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	114.89	16.57	7.20	10.80	4.32	0.00	1.80	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	110.77	11.51	8.63	8.63	2.59	0.86	1.44	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	129.16	13.91	7.78	11.31	4.24	0.24	2.36	0.71	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	151.48	25.67	6.97	11.73	4.12	0.32	1.90	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	151.63	23.37	4.92	11.99	5.84	0.31	1.54	0.62	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	121.82	22.44	5.77	15.39	6.73	0.00	1.60	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	156.43	22.57	5.35	9.56	6.12	0.76	3.82	1.15	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	166.71	18.13	8.67	12.61	3.94	0.39	4.73	1.18	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	178.51	24.21	9.08	12.86	9.08	0.76	3.03	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	330.82	28.91	17.67	24.89	20.07	1.61	2.41	4.82	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	349.01	23.08	14.69	24.48	20.28	2.10	4.20	2.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	248.43	34.06	19.03	21.04	11.02	2.00	5.01	7.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	173.64	20.11	0.00	0.00	9.14	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	108.70	7.41	2.47	1.48	2.47	0.49	0.49	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	90.61	8.94	1.89	2.00	2.10	0.32	1.26	0.21	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	129.65	16.64	2.43	5.55	3.47	0.35	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	61.12	4.62	1.42	2.49	1.42	0.00	1.42	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	109.23	10.58	4.78	2.50	2.39	0.11	1.37	0.00	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	164.73	21.49	6.27	1.79	5.37	3.58	0.00	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	101.10	10.51	6.07	3.24	7.28	1.21	1.21	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	336.13	36.15	11.25	6.66	4.93	1.03	1.61	0.46	0.34	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	205.86	28.22	7.48	5.99	3.85	0.21	0.86	0.43	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	226.82	23.45	9.38	7.08	5.40	0.88	1.50	0.27	0.09	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	156.07	16.14	17.61	6.51	17.33	1.10	1.47	1.83	0.83	0.37
Corneal Epithelial Cells, donor1	11526-119I5	18.44	0.88	2.20	1.98	0.22	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	55.74	0.00	3.41	1.14	1.14	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	59.31	4.35	2.81	1.79	0.51	0.00	0.51	0.51	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	90.31	6.44	3.96	2.48	4.46	0.17	1.16	0.17	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	84.85	7.57	4.42	1.89	4.42	0.63	1.89	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	110.42	6.90	0.00	3.45	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	73.97	7.34	3.02	3.56	3.35	0.32	0.32	0.22	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	460.53	35.53	32.46	17.08	31.43	1.02	3.76	0.00	0.68	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	545.80	45.70	20.89	8.49	24.16	1.31	3.26	0.00	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	529.44	59.04	23.23	10.65	25.65	0.48	0.48	0.48	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	53.37	5.84	2.33	1.50	4.00	0.17	0.50	0.33	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	42.83	3.52	1.17	0.59	2.93	0.00	0.59	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	60.80	3.11	3.39	1.70	3.39	0.00	0.85	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	47.97	4.72	1.97	1.57	5.50	0.00	0.79	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	63.41	11.05	1.75	2.91	2.62	0.29	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	130.34	16.47	3.53	3.06	3.76	0.24	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	79.94	9.99	2.45	2.63	2.98	0.53	0.00	0.53	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	113.26	10.64	6.21	2.22	7.76	1.11	1.77	0.44	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	122.01	11.87	3.96	1.52	3.96	0.91	0.91	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	134.19	12.12	3.10	2.82	7.05	0.56	0.56	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	54.08	5.94	2.67	2.38	2.67	0.59	0.00	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	41.13	7.81	1.04	1.04	4.17	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	48.21	6.95	3.83	2.27	4.25	0.43	0.28	0.00	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	208.86	22.81	4.80	2.80	10.00	0.40	0.00	2.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	37.21	4.19	1.05	0.52	4.72	0.00	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	341.80	32.06	8.95	4.97	7.45	5.22	1.99	0.75	0.37	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	160.34	18.90	7.60	2.17	5.43	0.65	1.09	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	191.37	20.27	5.25	3.05	7.21	0.85	0.61	0.37	0.00	0.12
Endothelial Cells - Vein, donor1	11267-116G7	47.78	10.24	4.55	3.41	3.41	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	38.42	4.89	3.49	2.79	6.99	0.00	0.00	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	88.39	10.21	2.83	3.14	4.55	0.79	0.47	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	548.89	45.74	15.25	0.00	91.48	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	221.14	16.50	8.25	1.65	18.15	3.30	4.95	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	206.88	17.83	3.57	0.00	17.83	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	20.52	1.95	1.47	1.71	0.49	0.00	0.24	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	107.55	11.90	1.64	4.11	2.46	1.23	1.23	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.53	1.97	0.33	0.66	0.77	0.11	0.33	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	86.45	8.13	1.73	3.68	2.82	0.11	0.87	0.11	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	218.79	22.19	3.52	3.64	5.34	2.06	1.70	0.49	0.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	291.64	19.92	6.96	4.78	7.78	0.82	0.27	0.68	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	93.34	9.60	1.90	2.53	2.95	1.16	1.16	0.42	0.00	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	266.13	15.02	5.80	4.74	5.53	1.05	0.00	0.79	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	196.99	19.60	7.64	7.31	1.99	1.00	0.66	0.00	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	95.72	10.89	3.18	2.72	3.18	0.00	0.00	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	53.81	3.03	0.76	3.79	1.52	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	77.60	8.20	1.26	3.31	1.73	0.63	0.16	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	166.71	15.16	4.55	4.24	3.94	1.82	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	153.68	13.71	4.06	2.16	2.66	0.38	0.38	0.00	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	172.82	16.98	3.49	3.03	2.12	0.00	0.15	0.00	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	73.16	7.37	3.35	2.41	3.35	0.27	0.00	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	97.50	12.94	2.59	4.31	1.73	0.00	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	142.08	13.18	7.32	2.93	1.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	90.41	7.15	7.38	4.15	2.77	0.46	0.69	0.00	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	114.82	5.94	1.70	2.88	1.36	0.51	3.56	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	108.70	8.92	2.58	2.35	0.70	0.70	0.23	0.00	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	62.26	6.13	2.83	0.94	4.25	0.00	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	154.37	18.01	3.26	6.04	3.02	1.09	0.85	0.60	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	238.98	28.83	7.23	5.20	3.17	0.45	0.45	0.11	0.11	0.00
Fibroblast - Dermal, donor5	11454-119A5	279.82	34.54	8.55	3.14	2.97	0.35	1.22	0.00	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	301.95	34.11	7.47	3.57	1.79	0.81	0.32	0.16	0.49	0.00
Fibroblast - Gingival, donor1	11237-116D4	156.59	10.41	2.08	1.46	1.87	0.42	1.46	0.42	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	180.26	20.96	4.98	5.24	8.12	1.05	0.00	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	259.09	22.14	5.80	3.56	2.37	0.40	1.32	0.13	0.13	0.00
Fibroblast - Gingival, donor3	11394-118C8	143.68	12.57	3.09	2.42	3.38	0.58	0.68	0.10	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	121.55	10.39	3.12	8.31	0.00	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	119.64	14.80	3.52	3.17	1.41	1.06	0.53	0.00	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	276.40	23.85	4.68	4.99	4.68	0.94	1.09	0.16	0.16	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	211.09	16.23	3.38	3.79	2.43	0.81	1.22	0.27	0.00	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	59.28	8.12	7.41	9.17	12.70	0.35	0.00	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	192.46	16.82	3.22	3.66	4.24	0.58	1.17	0.15	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	235.21	23.32	3.68	3.95	3.14	1.09	0.95	0.27	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	253.83	26.11	7.02	9.10	4.94	0.33	0.88	0.33	0.44	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	115.04	12.18	4.26	3.52	3.96	0.44	1.61	0.00	0.00	0.00
Fibroblast - Lung, donor1	11270-116H1	38.06	1.36	2.72	1.36	0.00	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	182.04	13.43	2.98	2.98	1.49	1.49	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	158.91	23.85	6.54	6.33	3.17	0.84	0.21	0.00	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	38.32	5.00	0.83	3.33	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	27.97	1.40	1.40	4.20	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	15.11	1.12	0.84	0.28	0.28	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	98.65	4.06	4.47	2.84	2.84	0.81	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	5.96	0.00	0.00	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	272.53	22.31	7.18	3.69	2.52	0.78	1.16	0.19	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	312.16	34.58	10.92	5.01	2.73	1.06	0.46	0.30	0.15	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	220.31	11.02	5.51	2.75	3.06	0.61	0.00	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	156.08	10.30	3.05	4.96	2.67	0.38	0.76	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	163.34	14.04	2.70	2.43	2.43	0.54	0.54	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	92.66	8.81	3.83	3.36	3.02	0.70	1.16	0.23	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	216.64	25.53	3.98	3.43	1.44	0.44	1.88	0.11	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	79.24	5.69	3.86	2.64	3.05	0.20	1.02	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	54.12	4.01	6.68	2.67	1.34	0.67	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	132.45	9.88	2.37	0.79	1.98	0.00	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	399.87	21.23	11.91	4.96	5.95	0.40	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	131.79	10.83	2.49	3.02	2.66	0.89	1.60	0.18	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	169.89	14.58	2.17	3.94	2.37	0.39	0.39	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	328.83	20.76	9.93	6.32	4.81	1.20	0.00	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	222.70	17.81	2.70	2.59	3.89	0.54	0.43	0.11	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	334.56	23.79	5.57	4.56	4.05	0.25	0.00	0.76	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	120.93	10.17	2.46	2.63	2.79	0.33	0.49	0.16	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	378.96	28.27	12.43	6.62	8.82	0.40	0.00	0.40	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	189.77	20.90	3.01	1.21	3.11	0.20	0.20	0.60	0.10	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	373.87	27.81	11.49	4.53	6.95	0.30	0.00	0.91	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	187.23	12.51	3.15	3.48	3.73	0.83	1.49	0.00	0.08	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	124.28	10.94	1.20	3.93	1.88	0.34	0.00	0.51	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	323.51	12.81	5.91	4.60	4.93	0.00	0.00	0.99	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	189.18	17.58	3.52	2.45	3.41	0.96	0.32	0.11	0.00	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	154.01	14.51	2.53	3.54	3.88	1.01	0.17	0.00	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	85.62	9.41	1.25	1.10	1.73	0.16	1.57	0.47	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2215.98	310.24	0.00	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	199.58	22.66	17.43	4.36	8.72	0.87	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	103.67	7.63	0.17	0.87	2.60	0.35	1.56	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	143.13	9.11	1.56	1.82	2.08	0.00	0.78	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	117.02	5.62	1.53	1.28	4.09	0.26	0.26	0.26	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	286.32	33.68	17.61	17.61	3.06	0.77	3.83	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	425.59	59.34	17.23	15.31	2.55	1.28	0.00	1.91	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	412.49	63.90	30.52	14.26	2.28	4.85	0.86	0.57	1.71	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	287.89	44.40	44.12	22.34	5.79	17.10	1.65	1.38	1.38	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	280.84	35.39	23.52	18.95	10.27	7.53	2.74	1.83	0.68	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	301.36	48.74	33.68	17.44	2.77	4.95	0.40	0.20	0.99	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	251.91	45.47	40.18	15.86	2.64	23.00	0.79	0.79	0.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	275.59	46.64	26.09	21.20	10.76	6.20	0.65	0.65	1.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	287.45	56.16	26.98	17.69	0.88	2.65	0.88	0.88	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	354.01	35.61	22.47	18.65	1.41	0.42	0.57	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	313.15	30.05	15.89	10.96	2.22	0.12	1.23	0.37	0.49	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	311.34	43.79	16.65	13.70	1.07	0.00	0.27	0.81	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	260.05	21.19	12.39	7.81	2.11	0.12	0.87	0.12	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	259.41	22.84	10.94	8.86	1.80	0.14	0.28	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	252.30	23.18	10.98	7.73	0.41	0.20	1.02	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	193.50	17.80	11.18	5.93	2.28	0.23	0.91	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	191.33	18.93	10.59	6.60	2.12	0.25	0.37	0.12	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	163.71	17.27	9.62	5.46	1.31	0.00	0.87	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	248.20	24.82	10.34	7.98	2.07	0.00	0.30	0.30	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	269.43	25.43	15.26	8.90	3.18	0.32	0.32	0.16	0.79	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	187.67	17.20	10.72	7.60	0.89	0.22	0.45	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	293.18	34.48	14.11	9.48	3.63	0.40	0.60	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	318.76	34.61	13.74	8.99	3.39	0.34	0.34	0.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	314.70	32.19	10.20	8.87	3.90	1.33	1.06	0.09	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	258.27	22.37	12.38	8.84	4.37	0.62	1.04	0.00	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	212.96	19.98	13.15	7.34	4.61	0.17	0.34	0.34	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	262.91	29.66	15.93	9.41	4.43	0.55	1.00	0.11	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	315.06	30.28	11.48	9.32	4.49	1.41	1.16	0.17	0.67	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	273.40	32.06	10.82	8.37	2.45	1.02	1.23	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	237.05	31.77	12.17	8.66	3.71	0.41	1.03	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	259.18	27.32	18.56	8.42	4.04	0.69	0.69	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	231.97	28.02	14.84	10.67	4.67	0.17	0.83	0.50	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	161.13	21.16	9.70	4.63	4.41	0.00	1.76	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	251.15	27.06	19.43	6.15	3.44	0.37	1.35	0.25	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	257.57	27.88	13.94	11.35	2.59	0.32	0.65	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	193.07	18.92	11.23	4.81	2.89	0.96	0.96	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	217.18	21.51	12.51	7.86	4.26	0.38	0.95	0.19	0.57	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	175.89	21.51	10.44	6.01	3.80	0.47	1.11	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	261.21	27.37	11.25	8.21	5.17	0.30	0.91	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	232.28	24.15	13.17	8.99	3.35	0.42	0.73	0.00	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	171.69	17.56	11.42	4.39	3.73	0.00	0.44	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	198.91	22.72	9.26	4.49	4.49	0.56	0.56	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	169.71	18.24	8.24	7.87	5.46	0.46	0.28	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	173.28	23.53	5.35	6.15	3.48	0.80	0.27	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	186.05	21.27	7.34	4.74	3.52	0.46	1.07	0.15	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	168.79	20.34	10.23	6.99	4.53	0.00	0.39	0.39	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	153.16	15.72	6.51	3.80	3.52	0.54	1.08	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	197.07	23.41	9.40	5.71	5.71	0.18	0.18	0.00	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	194.09	19.96	9.87	4.82	4.39	0.44	0.66	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	186.45	10.91	12.89	2.98	4.96	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	224.51	21.77	8.31	3.96	3.17	0.40	1.85	0.13	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	151.32	16.95	6.46	4.84	3.43	0.40	0.40	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	173.85	14.23	7.62	7.37	4.83	1.02	0.76	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	429.17	44.79	18.91	14.53	2.59	0.60	0.40	0.40	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	344.21	39.29	29.74	12.63	2.47	0.46	1.08	0.15	0.46	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	454.38	52.58	44.60	23.32	1.23	0.82	0.00	0.20	1.23	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	351.11	41.62	13.77	16.27	1.25	1.25	1.88	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	333.13	49.16	11.87	16.39	1.41	0.57	1.98	0.00	1.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	432.61	39.66	22.60	17.06	0.92	2.77	0.46	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	309.35	51.97	19.80	29.70	9.90	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	453.73	64.21	12.38	20.89	1.93	3.09	0.77	0.00	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	380.26	40.11	6.42	24.07	3.21	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	351.24	62.60	15.65	19.13	1.74	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	369.74	54.68	14.32	20.51	1.63	0.98	0.98	0.33	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	413.86	63.01	14.41	14.00	0.82	1.65	0.00	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	369.88	76.64	13.33	16.66	3.33	13.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	371.93	52.01	13.98	15.66	2.80	1.40	0.28	0.28	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	339.26	53.93	11.77	14.05	2.61	0.65	0.00	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	367.41	57.04	19.29	15.10	0.00	3.36	2.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	367.37	55.03	16.54	16.54	1.91	1.27	0.32	0.64	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	345.10	49.25	12.57	14.61	2.72	0.34	0.00	0.34	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	311.13	43.85	16.71	31.32	0.00	2.09	2.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	355.65	56.12	16.61	12.03	2.29	0.00	0.57	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	220.51	29.60	7.99	9.47	1.78	0.00	0.59	0.00	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	396.43	64.38	13.55	15.25	3.39	0.00	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	510.72	82.43	12.84	21.54	2.90	2.07	1.24	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	445.99	69.04	14.04	21.17	2.76	2.53	1.61	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	489.97	63.22	5.27	10.54	5.27	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	317.91	49.97	13.45	15.38	3.46	0.77	0.77	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	305.11	35.20	11.41	9.78	2.93	0.33	0.65	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	223.39	20.07	8.69	6.02	0.67	0.67	2.01	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	272.38	33.52	14.25	9.25	1.54	1.16	0.77	0.00	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	427.58	68.81	16.43	26.02	4.11	1.37	0.34	1.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	203.75	14.91	17.39	7.45	0.00	2.48	2.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	227.43	16.04	12.74	8.02	1.89	0.00	0.94	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	238.98	28.97	7.24	4.22	1.81	0.00	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	290.45	23.91	17.29	9.66	2.03	0.00	1.53	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	332.23	39.09	20.34	8.38	1.20	0.00	0.80	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	292.56	30.09	13.32	6.41	1.97	0.99	1.48	0.49	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	404.89	41.32	16.53	8.26	3.54	1.18	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	240.96	25.09	5.25	4.67	2.33	2.92	0.58	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	247.97	21.94	7.46	4.39	1.76	0.44	0.44	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	365.36	50.86	18.65	8.48	3.39	0.00	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	305.02	33.43	11.94	13.73	2.98	0.60	0.60	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	324.63	39.79	10.19	13.59	3.88	2.43	0.00	0.97	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	52.50	3.42	2.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	102.29	8.32	2.91	1.25	1.66	0.00	0.00	0.83	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	39.36	3.37	3.37	0.00	1.12	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	74.22	5.71	0.63	0.95	1.27	0.00	0.63	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	37.18	0.42	0.00	0.00	0.42	0.00	1.25	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	207.83	23.32	5.22	6.15	1.62	0.58	0.00	0.12	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	199.69	31.06	6.58	6.58	1.86	0.17	0.17	0.34	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	189.74	26.85	4.32	5.01	1.14	0.23	0.46	0.00	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	217.20	23.94	5.47	7.87	1.75	0.22	0.33	0.00	0.11	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	189.98	24.71	6.88	6.23	1.29	0.21	0.43	0.00	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	173.30	22.39	4.74	6.67	1.08	0.00	0.00	0.00	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	192.41	18.43	4.23	4.61	1.49	0.50	0.50	0.12	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	164.17	21.10	2.74	3.09	1.72	0.34	0.34	0.00	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	162.43	19.54	5.13	3.20	2.24	0.00	0.00	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	44.77	8.95	3.36	2.24	5.04	0.00	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	24.24	3.46	1.73	2.16	2.60	0.43	0.43	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	87.25	13.22	2.64	0.00	2.64	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	42.68	3.53	0.00	1.76	2.12	0.00	0.35	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	32.69	2.91	2.18	2.18	0.73	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	159.98	20.63	2.97	3.32	1.57	0.00	0.70	0.00	0.17	0.00
Hepatocyte, donor1	11523-119I2	123.48	3.63	13.32	2.42	4.84	0.00	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	172.37	23.70	7.54	4.31	1.08	0.00	0.00	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	148.48	13.50	15.34	5.52	5.52	1.23	0.00	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	379.86	71.80	60.70	7.83	13.71	1.31	0.00	1.31	3.92	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	257.80	29.71	4.37	5.77	2.27	3.15	1.75	0.00	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	118.00	10.02	2.06	1.10	1.37	0.27	0.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	9.55	19.10	9.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	6.68	13.35	6.68	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	48.45	8.31	9.69	6.92	8.31	0.00	0.00	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	2.50	15.02	7.51	7.51	0.00	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	11.87	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	0.00	15.38	10.25	12.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	4.57	9.14	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	50.35	3.25	8.12	9.75	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	56.69	10.00	15.01	13.34	1.67	0.00	0.00	0.00	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	3.63	14.52	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	58.23	5.29	27.79	7.94	3.97	0.00	0.00	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	66.52	2.22	12.20	3.33	3.33	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	5.24	10.48	15.71	0.00	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	69.28	5.67	12.60	12.60	5.04	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	7.73	15.47	7.73	3.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	14.63	29.27	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	61.37	5.17	20.67	9.69	7.11	0.00	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	41.86	1.61	32.20	9.66	6.44	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	11.95	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	49.71	3.26	17.11	15.48	5.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	32.75	3.36	9.24	8.40	3.78	0.00	0.00	0.42	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	14.37	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	67.51	4.82	15.27	18.48	5.63	0.00	0.00	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	52.63	8.31	16.62	4.62	3.69	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	55.23	3.78	10.38	7.55	2.83	0.00	0.47	0.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	48.07	4.53	8.16	11.79	1.81	0.00	0.00	0.00	2.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	0.00	0.00	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	48.43	4.30	17.22	13.99	4.30	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	71.15	6.35	15.25	10.16	6.35	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	32.86	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	45.28	3.83	14.67	13.39	8.29	0.00	0.00	0.00	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	47.39	1.82	14.58	14.58	5.47	0.00	1.82	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	15.80	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	44.99	8.57	16.42	10.00	2.14	0.00	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	0.00	33.18	16.59	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	80.87	6.79	6.48	10.80	4.63	0.00	0.00	0.62	0.00	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	3.51	12.29	12.29	1.76	0.00	0.00	0.00	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	0.00	22.00	6.29	3.14	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	47.98	2.78	18.78	8.34	5.56	0.00	0.00	0.70	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	17.70	4.43	11.07	2.21	2.21	0.00	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	3.24	12.97	6.48	0.00	0.00	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	40.98	2.62	10.46	8.72	0.87	0.00	0.87	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	31.50	2.25	22.50	2.25	4.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	3.48	3.48	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	4.27	13.87	9.60	4.27	0.00	0.00	2.13	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	41.56	2.77	8.31	6.93	2.77	0.00	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	5.70	22.80	14.25	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	36.82	1.84	10.12	11.97	4.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	3.03	21.18	0.00	9.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	12.42	6.21	0.00	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	0.00	19.03	3.17	4.23	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	113.42	9.79	2.28	1.31	1.80	0.33	1.22	0.08	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	26.94	1.76	1.76	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	257.37	20.54	4.45	3.88	1.51	0.28	0.76	0.09	0.19	0.09
Keratinocyte - oral, donor1	11251-116E9	188.33	14.19	5.22	1.82	2.27	0.23	1.93	0.00	0.45	0.00
Keratocytes, donor1	11527-119I6	74.27	3.44	5.50	2.75	2.75	0.00	0.69	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	50.39	4.69	1.17	0.00	1.17	0.00	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	141.87	10.87	5.73	1.98	1.78	0.00	1.38	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	103.30	10.99	17.58	6.59	17.58	0.00	0.00	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	154.26	12.94	4.31	3.24	4.31	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	164.00	10.84	4.61	2.65	0.81	0.35	1.50	0.00	0.35	0.00
Lens Epithelial Cells, donor3	11690-122I7	67.81	7.97	1.41	1.51	2.12	0.10	0.91	0.00	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	66.05	5.81	1.90	1.90	3.20	0.24	0.95	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	54.42	6.14	3.35	4.74	3.63	0.84	1.95	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	115.23	10.39	4.09	2.83	5.82	0.16	2.20	0.16	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	59.15	6.45	1.61	2.69	4.30	0.00	1.08	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	35.30	2.84	2.21	1.89	1.89	0.63	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	39.24	4.53	1.83	2.16	2.80	0.00	1.19	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	91.52	9.85	2.87	2.05	3.69	0.82	0.41	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	30.34	2.28	2.53	3.79	2.53	0.00	1.01	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	52.08	4.79	3.24	2.25	3.80	0.14	0.56	0.42	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	87.41	9.89	1.58	3.16	2.77	0.00	1.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	91.51	9.50	4.07	3.30	4.65	0.58	1.94	0.58	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	21.48	1.48	2.04	1.48	2.22	0.00	1.30	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	79.79	9.06	1.74	1.74	2.09	0.00	1.74	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	67.26	7.63	3.82	2.62	3.58	0.24	2.15	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	51.64	4.81	2.88	3.02	3.71	0.00	0.55	0.14	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	97.62	11.09	2.77	2.46	1.54	0.92	0.92	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	36.47	4.36	2.18	2.49	3.43	0.00	1.87	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	49.77	5.49	3.84	1.65	4.03	0.00	0.18	0.18	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	79.32	9.22	2.63	2.30	3.62	0.66	0.00	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	36.61	5.27	2.93	1.76	2.93	0.29	1.46	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	27.88	3.73	2.49	1.49	2.99	0.50	0.50	0.25	0.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	97.48	10.67	3.88	4.36	4.85	0.00	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	86.17	10.23	4.04	3.23	4.85	0.27	2.15	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	77.51	8.48	3.48	3.48	3.94	0.15	0.76	0.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	55.99	3.63	1.56	1.56	4.67	0.00	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	126.05	12.77	3.77	4.19	5.44	0.21	3.14	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	67.52	7.97	4.66	3.76	4.51	0.15	1.80	0.60	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	65.35	4.82	1.38	3.44	2.75	0.00	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	79.40	8.65	3.95	2.63	4.33	0.00	1.51	0.38	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	46.55	4.67	2.23	2.65	3.18	0.00	1.59	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	82.86	9.69	1.45	1.94	2.91	0.00	0.48	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	65.17	3.97	1.98	1.65	1.98	0.33	0.66	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	44.60	3.72	2.35	2.60	3.59	0.25	0.50	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	118.10	14.44	5.18	3.33	4.07	1.11	1.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	99.33	7.66	3.21	3.71	5.44	0.25	0.74	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	44.27	5.09	2.47	2.47	1.92	0.00	1.79	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	96.49	12.87	2.89	2.89	2.57	0.32	0.96	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	136.95	16.13	4.87	3.65	3.35	0.61	1.83	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	123.45	11.90	4.06	3.78	5.60	0.28	2.24	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	81.78	6.40	3.91	4.62	4.27	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	42.66	3.39	0.48	2.42	5.82	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	31.43	2.33	2.02	1.09	2.96	0.00	1.24	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	56.22	5.37	2.15	2.15	2.15	0.36	1.79	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	67.62	5.23	3.27	2.94	3.59	0.33	0.33	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.95	1.18	0.94	1.41	0.47	0.00	0.94	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	42.57	4.46	1.11	1.98	1.86	0.12	1.11	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	58.65	1.79	2.31	1.28	1.79	0.26	0.77	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	40.87	4.18	2.09	1.49	2.69	0.60	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	56.65	6.80	20.39	4.53	6.80	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	58.30	5.37	12.27	5.37	3.84	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	48.24	2.23	8.16	3.71	7.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	70.24	7.62	13.54	5.92	8.46	0.42	0.00	0.85	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	47.83	7.74	17.58	3.52	4.92	0.70	0.70	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	49.50	3.74	14.01	3.74	4.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	68.53	9.79	14.43	3.61	3.61	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	44.01	10.71	26.17	5.95	5.95	1.19	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	78.72	11.08	11.31	5.43	6.33	0.45	1.58	0.68	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	110.51	19.19	11.34	4.07	5.82	0.00	1.16	0.29	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	102.64	18.46	13.96	4.95	5.85	0.90	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	78.85	10.43	15.72	8.13	7.72	0.81	1.08	0.41	0.95	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	73.95	13.87	15.92	8.22	5.14	0.51	1.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	87.86	7.41	14.47	4.94	6.00	0.35	0.71	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	79.96	17.99	11.33	8.00	1.33	1.33	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	86.09	9.68	14.77	4.58	7.64	1.02	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	107.26	13.07	13.34	4.54	4.80	0.27	1.60	0.27	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	98.25	15.30	19.65	6.61	7.37	1.13	0.76	0.76	0.76	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	69.95	17.18	15.34	6.14	7.98	0.00	0.61	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	88.07	13.05	14.68	5.71	7.34	0.82	0.00	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	102.25	17.28	13.54	6.04	6.46	0.42	1.46	0.62	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	113.23	17.38	9.25	4.76	7.29	1.40	1.12	0.28	1.40	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	69.03	11.33	11.33	9.27	10.30	0.00	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	109.44	11.90	15.39	4.94	7.84	0.29	1.45	0.00	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	107.32	14.05	6.88	5.68	3.29	0.30	0.60	0.60	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	96.27	13.28	16.04	3.87	6.09	0.55	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	85.54	7.78	16.61	7.07	4.24	0.00	0.00	1.06	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	81.13	16.23	16.60	4.43	6.64	0.37	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	71.38	9.21	11.51	5.76	10.36	0.00	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	69.84	4.99	21.87	6.91	6.52	0.38	0.77	1.15	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	75.30	10.19	11.89	5.10	7.36	0.57	0.57	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	79.59	9.03	11.49	3.28	3.28	0.00	1.64	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	60.55	9.49	17.62	9.49	7.23	0.00	0.45	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	68.22	10.77	13.64	7.90	3.59	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	61.25	4.48	17.93	2.99	3.73	0.00	0.75	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	63.17	8.92	15.61	6.69	4.83	0.74	0.37	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	81.41	9.91	12.49	6.03	5.17	0.00	0.00	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	70.22	5.99	15.41	2.57	2.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	63.97	13.66	12.66	8.00	5.00	0.00	0.00	0.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	62.14	6.03	15.69	1.81	4.22	0.00	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	54.75	7.82	12.09	7.11	5.69	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	63.93	3.09	13.06	3.09	3.44	0.00	0.69	0.00	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	49.92	4.83	12.35	1.07	2.68	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	48.48	7.41	12.12	5.39	4.71	0.67	1.35	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	65.93	6.30	19.26	6.67	4.44	0.00	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	66.29	4.65	9.30	4.65	6.98	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	55.00	3.17	14.81	2.12	3.17	0.00	1.06	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	79.63	10.00	16.41	4.80	6.80	0.00	1.20	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	55.24	5.81	15.26	5.09	11.63	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	55.96	9.20	23.00	9.96	11.50	0.77	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	54.75	8.39	14.80	7.89	8.39	0.49	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	59.28	8.47	16.00	4.70	9.41	0.00	0.00	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	57.32	9.05	24.14	12.07	10.56	0.50	0.00	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	64.89	8.56	20.28	13.52	14.42	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	63.68	10.33	12.05	10.33	8.61	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	55.67	13.36	28.95	10.24	5.34	0.45	0.89	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	68.04	7.82	21.51	7.82	8.21	0.39	0.00	0.39	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	71.25	10.56	14.51	5.94	5.94	0.66	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	63.83	6.75	26.98	16.09	7.26	0.52	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	70.45	14.00	24.50	10.94	8.31	0.44	0.44	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	78.83	11.74	18.45	2.24	8.39	0.56	0.00	0.56	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.53	7.07	21.20	7.07	4.86	0.44	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	70.59	8.49	18.51	9.26	5.79	0.39	0.39	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	82.03	12.66	19.24	6.08	7.09	0.00	0.00	0.51	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	62.00	8.17	16.82	5.77	7.21	0.00	0.48	0.48	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	78.32	9.14	21.07	5.57	4.77	0.40	1.99	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	87.50	12.76	16.41	7.29	6.08	0.61	1.22	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	93.38	9.68	15.91	6.92	3.46	0.00	0.69	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	77.52	8.74	20.52	4.56	6.46	1.14	1.14	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	73.33	12.39	13.94	6.71	9.30	0.00	2.07	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	86.47	6.65	16.93	5.44	4.84	1.21	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	91.58	13.63	13.63	8.24	6.02	0.00	0.63	0.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	77.30	9.06	21.86	8.53	4.26	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	88.50	8.62	20.69	6.90	6.32	0.00	0.00	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	75.08	9.26	24.68	4.11	3.60	0.51	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	93.37	12.03	21.22	3.54	8.49	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	72.07	5.67	13.62	6.24	5.11	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	95.69	12.48	19.97	7.07	4.99	0.42	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	94.75	8.61	18.01	6.26	3.13	0.78	2.35	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	66.81	6.26	18.37	6.68	2.51	0.00	0.42	0.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	61.33	11.15	19.05	7.43	4.18	0.00	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	75.60	11.37	10.70	4.01	4.68	0.00	0.00	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	73.78	9.62	11.76	4.81	3.74	0.00	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	74.76	11.31	19.40	4.45	5.25	0.00	1.21	0.81	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	70.67	7.34	13.77	4.59	5.51	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	91.58	8.00	10.67	2.67	2.67	0.00	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	62.69	5.70	15.96	5.70	3.99	0.00	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	71.32	9.20	13.04	5.37	3.83	0.77	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	103.96	6.02	6.57	2.19	1.64	0.55	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	71.27	8.02	16.48	8.46	8.02	0.00	0.00	0.89	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	77.21	6.24	9.10	5.20	5.46	0.00	1.56	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	90.85	7.96	12.60	4.64	4.64	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	4.16	14.55	10.39	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	123.76	9.80	3.65	4.10	5.24	0.23	1.60	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	88.82	7.34	1.28	2.57	2.75	0.55	0.37	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	91.49	8.39	3.67	2.10	4.72	0.13	0.52	0.39	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	124.79	9.56	0.53	0.53	1.59	0.00	1.06	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	135.79	14.26	1.27	1.43	2.06	0.16	1.27	0.32	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	171.37	18.62	3.20	0.83	2.78	0.00	0.69	0.00	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	235.06	30.69	6.98	10.56	5.68	0.60	2.09	0.70	0.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	239.46	24.32	6.66	6.66	0.87	0.00	0.87	0.29	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	52.88	4.99	1.75	2.74	1.00	0.00	0.00	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	630.48	91.52	9.49	4.07	9.49	12.20	0.00	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	177.89	17.09	15.14	4.65	12.54	7.68	2.16	1.08	0.11	0.32
Mast cell, donor2	11565-120D8	301.63	30.01	36.85	15.45	24.07	14.26	4.16	1.19	0.30	2.97
Mast cell, donor3	11566-120D9	262.50	32.87	38.72	15.98	27.47	14.41	1.80	1.35	0.23	0.90
Mast cell, donor4	11567-120E1	271.96	26.77	38.83	12.59	16.67	18.08	1.77	1.24	0.18	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	218.68	20.96	13.42	10.20	16.19	4.66	0.89	2.11	0.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	242.81	24.51	5.84	5.25	19.26	6.42	0.00	2.33	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	169.79	20.31	12.39	4.59	18.01	9.52	0.69	1.03	0.11	0.23
Mast cell, expanded, donor8	11941-126A6	187.28	17.07	11.88	3.85	31.80	7.70	1.34	1.84	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	132.73	12.84	3.38	2.39	3.78	0.30	1.39	0.50	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	116.28	12.11	0.69	2.08	1.38	0.00	0.69	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	212.98	25.72	13.26	8.84	4.20	0.51	0.36	0.14	0.43	0.07
Melanocyte - light, donor1	11274-116H5	31.26	3.06	3.06	1.65	2.12	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	20.47	2.05	0.68	2.05	5.46	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	39.89	0.87	1.73	2.60	1.73	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	232.51	22.28	8.75	5.31	2.50	0.31	0.62	0.00	0.21	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	168.63	15.06	4.57	2.69	2.69	0.27	0.54	0.27	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	176.52	19.02	8.04	3.75	2.41	0.00	0.27	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	151.35	14.27	4.47	2.48	2.73	0.12	0.25	0.37	0.25	0.00
Meningeal Cells, donor2	11573-120E7	114.44	9.24	3.08	4.84	1.32	0.00	0.00	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	380.12	37.08	6.60	7.58	3.75	1.22	1.14	0.33	0.08	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	182.50	13.69	3.99	3.14	1.43	0.00	0.29	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	132.83	9.76	2.82	3.92	3.42	0.70	1.31	0.10	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00	0.00	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	18.31	2.62	2.62	3.92	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	167.92	14.35	5.02	4.31	0.72	0.00	0.00	0.00	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	121.13	10.16	3.60	2.75	1.69	0.21	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	128.68	16.08	3.02	1.01	2.51	1.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	62.19	4.83	3.74	1.98	1.32	0.00	0.44	0.00	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	78.90	4.38	3.65	5.84	1.46	0.73	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	58.93	4.30	1.84	2.66	2.25	0.20	0.41	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	118.42	12.47	2.22	1.11	1.52	0.28	0.28	0.28	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	1.86	0.37	1.86	1.12	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	110.13	9.47	1.97	1.71	0.79	0.13	6.58	0.13	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.91	0.30	0.59	0.89	1.48	0.00	0.89	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	2.34	0.00	0.00	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	80.05	3.84	2.56	1.92	0.00	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	215.15	25.17	5.32	2.48	1.77	0.35	1.42	0.00	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	98.51	5.00	2.50	1.25	0.63	0.00	1.25	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	174.89	27.58	6.53	2.90	0.73	1.45	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	76.37	3.18	1.33	1.06	1.33	0.80	1.59	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	69.56	2.50	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	88.31	7.15	1.01	1.01	1.88	0.51	1.01	0.07	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	32.41	5.40	1.35	0.00	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	89.89	7.88	2.46	1.72	2.46	0.00	1.23	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	81.86	6.77	2.06	1.47	2.65	0.00	1.18	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	6.91	0.00	3.46	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	72.53	5.89	1.86	3.10	2.17	0.31	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	69.49	6.22	1.87	2.28	1.66	0.21	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	4.63	2.32	0.00	11.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	96.85	7.26	3.00	3.50	2.25	0.00	0.50	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	82.39	3.26	0.93	1.40	4.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	89.62	7.52	2.24	2.03	1.42	0.00	0.20	0.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	81.96	2.77	2.77	1.19	1.19	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	63.72	2.65	0.88	1.77	2.65	0.00	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	78.65	5.70	1.90	2.28	1.90	0.00	1.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	1.32	1.32	1.32	3.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	83.40	7.43	1.49	1.91	3.18	0.00	1.70	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.07	3.68	0.92	0.00	3.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	80.18	6.86	1.79	2.38	2.98	0.00	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	0.00	0.00	0.00	5.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	104.38	8.03	2.76	1.51	2.01	0.00	1.76	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	69.64	5.23	0.95	1.66	0.71	0.24	1.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	35.94	4.42	1.11	0.55	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	96.93	7.37	0.69	1.61	1.15	0.23	0.69	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	58.47	3.58	1.47	1.05	0.84	0.00	0.63	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	61.35	7.95	1.02	2.04	0.82	0.20	1.02	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	93.75	7.29	1.72	0.64	1.29	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	55.35	3.56	0.44	0.67	0.44	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	75.56	5.69	0.44	0.88	0.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	38.53	2.53	0.51	1.01	0.00	0.00	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	23.20	1.66	0.00	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	79.91	4.35	0.82	1.09	0.82	0.00	1.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	50.58	3.53	0.00	0.29	0.00	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	4.36	0.00	0.00	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	57.19	1.92	0.48	1.92	0.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	52.43	3.60	0.00	0.80	1.20	0.00	1.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	53.56	3.50	0.50	2.00	0.50	0.00	1.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	26.50	0.00	2.04	2.04	4.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	79.26	3.07	0.44	0.44	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	2.21	0.00	1.10	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.14	2.56	0.00	1.28	3.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	98.92	5.45	0.25	0.50	0.50	0.00	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	35.49	2.78	0.70	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	35.36	0.00	4.42	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	79.66	5.13	1.03	1.03	2.05	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	36.32	3.94	1.31	1.31	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	40.84	1.78	1.07	4.26	3.20	0.00	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	105.77	7.29	1.96	1.68	3.09	0.00	0.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	59.85	4.16	0.42	1.66	2.49	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	45.45	4.08	2.91	1.17	7.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	114.63	9.05	3.32	2.41	2.11	0.00	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	73.88	4.17	2.09	2.50	1.67	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	101.59	12.01	2.77	0.00	4.62	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	66.59	5.12	0.00	1.14	3.98	0.00	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	77.24	8.43	1.38	1.38	3.45	0.14	0.41	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	102.62	9.85	1.30	2.07	3.63	0.00	0.00	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	62.20	5.58	0.00	0.43	1.29	0.00	0.00	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	34.30	3.81	2.54	0.64	5.08	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	89.67	7.47	1.87	0.27	2.40	0.00	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	69.15	7.78	1.50	1.50	2.99	0.30	0.30	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	64.13	2.83	2.26	2.40	5.65	0.00	0.57	0.42	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	102.56	4.78	2.23	1.27	2.23	0.00	0.32	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	74.52	7.52	1.55	1.11	2.43	0.22	0.44	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	47.02	6.45	0.76	0.76	6.83	0.38	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	120.18	9.94	2.84	0.85	3.69	0.28	0.57	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	73.74	5.90	0.98	0.49	2.46	0.00	0.25	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	41.71	4.56	4.56	0.65	7.17	0.00	0.65	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	92.32	6.76	2.06	1.18	2.35	0.59	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	76.41	6.63	1.44	1.15	2.88	0.29	0.29	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	113.75	9.89	2.06	1.24	7.42	0.00	0.00	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	89.93	8.34	3.57	0.60	5.96	0.00	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	105.47	0.00	0.00	0.00	7.53	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	112.28	7.13	1.78	3.56	7.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	160.67	13.14	5.26	2.63	3.29	0.66	1.64	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	96.78	10.52	1.05	3.16	2.10	1.05	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	111.30	7.31	1.58	4.35	5.14	0.00	1.38	0.40	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	85.68	10.24	0.93	1.86	2.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	142.33	10.14	4.13	2.63	6.76	0.38	2.25	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	64.72	5.59	2.40	2.13	2.13	0.27	0.80	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	153.14	13.80	1.92	1.92	3.28	0.23	1.24	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	69.99	3.68	2.21	1.47	4.42	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	137.78	11.36	2.93	2.56	4.03	0.37	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	136.89	3.11	7.78	0.00	6.22	3.11	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	297.68	26.72	5.34	1.07	4.81	0.00	0.53	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	127.51	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	102.00	9.09	4.04	2.02	8.08	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	146.73	10.54	0.84	3.37	2.11	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	196.12	14.98	2.72	1.36	9.53	0.00	1.36	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	120.17	12.08	1.91	0.64	6.36	1.27	2.54	2.54	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	123.91	12.96	0.81	0.00	3.24	0.00	3.24	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	128.39	12.08	3.02	4.53	1.51	0.00	0.00	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	216.99	34.26	11.42	0.00	28.55	0.00	0.00	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	384.97	48.94	13.05	22.84	42.41	3.26	3.26	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	237.62	19.01	4.75	4.75	4.75	0.00	0.00	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	238.43	37.65	50.20	25.10	25.10	0.00	0.00	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	125.81	13.57	3.23	3.02	4.52	0.86	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	153.65	15.68	4.18	7.84	8.36	1.05	1.57	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	91.45	4.67	1.33	6.01	4.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	40.90	4.59	3.76	6.68	5.01	0.00	0.42	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	113.13	21.49	10.08	4.75	5.70	0.19	0.57	0.38	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	199.48	31.92	3.19	9.58	4.79	0.00	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	35.36	2.72	1.36	4.08	4.08	0.00	1.36	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	312.40	71.67	11.03	1.84	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	68.22	2.93	1.26	3.77	4.19	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	63.22	7.44	1.86	3.49	4.18	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	49.72	4.05	2.97	2.97	2.16	0.54	1.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	115.84	13.24	3.78	2.94	3.99	0.00	0.00	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1247.09	200.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	67.50	4.96	1.99	2.98	1.99	0.00	0.00	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	64.42	7.58	3.52	2.17	2.44	0.00	0.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	44.88	3.40	0.68	0.91	1.59	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	50.95	5.39	2.78	2.94	1.96	0.16	0.65	0.16	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	117.92	9.48	3.83	3.10	3.65	0.73	0.55	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	73.73	3.71	2.65	1.59	2.65	0.00	0.00	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	51.03	2.40	0.60	3.00	3.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	100.09	16.41	6.89	1.64	3.61	0.33	2.30	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	36.43	3.09	1.30	1.63	0.98	0.16	0.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	124.35	9.70	2.65	3.17	3.53	0.53	0.88	0.00	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	70.32	4.92	1.41	0.70	4.22	0.00	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	50.11	3.22	2.76	4.14	1.84	0.00	0.92	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	58.48	4.82	1.93	3.53	3.53	0.00	0.64	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	71.74	8.62	3.79	2.07	2.76	0.34	1.03	1.03	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	252.84	65.74	25.28	2.53	0.00	0.00	2.53	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	97.80	9.13	4.01	5.35	7.35	0.22	0.22	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	59.70	4.66	1.69	4.66	2.54	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	59.81	6.41	2.14	3.09	2.85	0.24	0.47	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	65.25	6.01	1.72	4.72	3.43	0.43	1.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	920.83	90.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	46.32	3.67	3.00	1.67	3.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	73.94	7.21	1.80	4.06	4.06	0.00	0.00	0.90	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	57.93	3.97	1.59	3.57	1.98	0.00	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	69.65	3.71	1.86	4.64	0.93	0.00	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	70.38	8.70	1.89	4.16	3.03	0.00	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	48.88	2.93	0.33	3.26	2.93	0.00	0.65	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	37.04	1.31	1.31	6.54	3.49	0.44	0.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	102.22	9.05	2.26	1.81	5.88	0.00	1.81	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	59.97	6.17	1.76	0.88	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	70.47	4.65	2.66	5.32	1.99	0.00	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	67.96	2.48	1.98	3.47	1.98	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	28.71	2.68	0.38	2.68	2.30	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	114.02	12.40	5.14	3.02	3.02	0.30	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	103.00	11.94	4.20	4.64	3.32	0.22	0.44	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	66.41	1.36	0.68	4.07	2.71	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	480.30	66.42	25.55	0.00	5.11	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	99.99	4.88	1.22	1.83	0.61	0.00	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.96	0.31	2.20	5.67	1.26	0.00	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	48.73	2.72	2.12	4.84	4.24	0.30	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	75.16	7.12	1.58	0.00	5.54	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	103.16	13.60	13.60	2.27	6.80	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	556.37	96.10	5.06	0.00	0.00	0.00	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	112.80	13.67	3.48	2.61	3.11	0.25	0.99	0.50	0.00	0.00
Myoblast, donor2	11322-117D8	125.62	17.45	3.45	4.22	2.88	0.77	1.73	0.19	0.00	0.00
Myoblast, donor3	11398-118D3	158.24	15.98	3.20	5.21	7.06	0.34	1.01	0.67	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	164.32	14.89	14.30	3.79	11.53	1.31	0.88	1.61	0.44	0.15
Natural Killer Cells, donor1	11230-116C6	544.30	50.74	34.13	4.61	77.19	4.31	3.69	6.15	0.62	2.77
Natural Killer Cells, donor2	11311-117C6	439.97	36.49	38.00	4.82	65.14	1.21	4.52	3.92	0.90	2.71
Natural Killer Cells, donor3	11387-118C1	454.06	42.15	35.34	6.81	73.25	2.39	2.39	4.79	0.55	4.60
Neural stem cells, donor1	11275-116H6	749.83	72.95	18.51	21.41	9.44	14.52	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	670.12	77.03	51.99	21.18	15.41	3.85	1.93	0.00	1.93	0.00
Neurons, donor1	11494-119E9	540.50	62.58	38.69	12.52	12.52	0.00	2.28	0.00	0.00	0.00
Neurons, donor2	11574-120E8	507.48	54.60	29.50	6.60	9.69	1.10	0.44	0.44	0.88	0.00
Neurons, donor3	11655-122E8	402.04	60.02	27.95	7.40	7.40	0.82	1.64	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	153.12	24.13	4.64	1.86	1.86	0.93	0.93	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	98.56	11.60	2.90	0.00	2.90	0.00	5.80	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	109.34	17.10	3.05	0.00	5.50	1.22	0.61	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	99.74	9.97	2.73	1.78	0.95	0.24	3.21	0.00	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	61.86	3.58	1.95	1.30	1.95	0.00	0.00	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	93.86	7.42	1.80	2.21	0.80	0.20	0.60	0.20	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	133.80	13.21	2.89	5.23	4.40	0.28	0.96	0.28	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	181.22	18.53	3.18	3.76	4.78	0.43	1.30	0.14	0.00	0.00
Olfactory epithelial cells, donor3	11935-125I9	122.81	8.51	1.93	3.29	3.41	0.11	0.91	0.11	0.00	0.00
Olfactory epithelial cells, donor4	11936-126A1	130.32	11.49	3.02	4.29	2.14	0.29	2.73	0.10	0.00	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	166.70	11.43	4.21	2.41	4.21	0.00	0.60	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	43.39	3.19	1.06	1.28	1.28	0.64	0.85	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	35.44	2.29	0.00	0.00	0.00	2.29	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	63.93	5.59	2.48	4.34	0.62	0.00	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	69.38	7.43	2.35	3.13	1.95	0.00	0.39	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	263.37	32.31	2.81	7.73	1.40	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	110.90	11.91	2.13	5.33	2.31	0.00	0.36	0.18	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	185.32	18.95	2.70	2.61	2.61	1.94	1.77	0.00	0.08	0.08
Pericytes, donor1	11491-119E6	18.14	0.89	1.67	0.89	1.00	0.00	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	31.24	3.40	1.81	4.75	1.58	0.00	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	44.76	5.70	2.85	1.63	1.63	0.00	0.61	0.41	0.00	0.00
Perineurial Cells, donor1	11499-119F5	183.21	13.45	3.73	4.18	3.05	0.45	0.79	0.11	0.11	0.00
Perineurial Cells, donor2	11579-120F4	140.32	10.58	1.93	2.58	2.30	0.28	0.83	0.00	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	500.74	39.20	28.37	7.33	39.52	1.59	2.55	4.14	0.64	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	341.34	27.91	22.28	4.90	26.69	0.73	3.43	1.96	0.73	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	362.49	39.34	31.58	4.53	42.97	0.78	1.29	2.98	0.26	2.72
Placental Epithelial Cells, donor1	11278-116H9	102.36	11.48	4.30	5.50	3.35	0.72	0.24	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	113.11	11.09	1.11	6.65	1.11	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	84.62	7.46	3.14	3.93	2.94	0.00	0.20	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	35.76	3.80	0.32	0.63	1.27	0.00	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	111.80	6.75	1.69	1.69	4.13	0.56	0.75	0.38	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	223.85	14.23	4.44	2.22	7.44	0.26	0.39	0.52	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	109.65	11.26	2.48	2.70	3.60	0.23	0.23	0.23	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	123.93	9.27	1.70	2.45	2.56	0.85	1.07	0.21	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	122.21	10.91	0.87	1.31	0.87	0.00	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	103.43	10.31	1.58	3.29	3.29	0.14	1.15	0.14	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	38.39	2.95	0.00	0.00	0.98	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	46.07	6.45	2.15	3.07	1.84	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	301.56	34.18	3.36	6.20	1.24	0.53	0.35	0.00	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	194.98	34.23	3.92	8.51	2.21	2.04	0.68	0.34	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	286.71	28.50	3.54	7.36	3.17	2.14	0.75	0.09	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	194.66	24.39	4.14	4.60	1.38	0.46	0.46	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	182.55	25.91	3.76	5.12	1.99	0.94	1.04	0.10	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	245.59	28.36	3.32	9.35	2.11	6.94	1.96	0.30	0.00	0.00
Prostate Epithelial Cells, donor2	11331-117E8	72.85	6.91	0.95	1.22	1.90	1.35	0.27	0.00	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	77.40	3.67	2.33	3.00	1.16	0.92	1.04	0.43	0.06	0.00
Prostate Stromal Cells, donor1	11254-116F3	196.14	21.07	2.05	3.64	1.48	1.59	1.25	0.23	0.00	0.00
Prostate Stromal Cells, donor2	11332-117E9	207.63	22.59	2.69	5.20	3.05	0.90	0.72	0.18	0.18	0.00
Prostate Stromal Cells, donor3	11405-118E1	91.45	6.88	2.71	1.67	1.04	1.25	0.42	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	41.24	1.82	3.28	4.01	0.73	0.73	1.09	0.00	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	138.76	10.60	3.05	2.08	1.18	0.28	1.87	0.14	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	29.42	2.54	3.04	3.04	1.01	0.00	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	51.22	6.40	4.27	2.85	0.71	0.00	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	189.50	16.41	3.18	2.65	2.22	0.21	1.06	0.00	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	16.34	1.36	0.68	2.04	1.36	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	61.32	5.66	1.62	2.16	2.70	0.00	0.27	0.81	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	175.17	19.76	4.00	3.55	6.66	0.67	0.44	0.67	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	2.00	3.33	2.66	0.67	0.00	0.67	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	42.48	3.52	1.76	4.18	2.86	0.22	0.22	0.22	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	57.68	8.15	4.39	1.88	5.02	0.63	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	21.08	2.22	3.61	2.22	1.39	0.00	1.11	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	82.41	4.03	2.95	2.15	1.07	0.00	0.00	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	60.72	5.48	2.95	2.95	0.84	0.84	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	71.35	7.33	3.28	3.47	2.31	0.00	0.39	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	152.20	11.93	4.67	2.85	1.30	0.00	0.26	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	67.65	5.97	4.83	2.56	1.14	0.28	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	44.25	8.23	6.17	2.06	1.03	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	153.05	15.05	3.76	3.76	3.01	0.75	0.50	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	191.90	17.37	8.02	5.35	4.81	0.40	3.61	0.94	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	181.36	33.95	13.40	5.36	4.47	0.89	2.68	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	340.68	34.12	12.11	2.75	9.91	3.85	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	332.95	53.37	19.14	7.54	11.02	1.16	3.48	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	223.12	45.64	9.62	3.38	11.05	0.39	0.00	0.39	0.65	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	187.59	32.27	12.21	7.15	9.63	0.60	0.70	0.30	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	278.18	40.27	13.61	7.47	10.04	1.23	0.78	0.45	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	266.82	43.91	13.27	5.33	9.06	0.37	0.37	0.37	0.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	192.18	30.42	15.03	6.41	8.39	0.35	1.05	0.12	0.23	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	256.09	39.75	14.33	4.85	7.86	0.92	0.92	0.69	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	187.56	20.67	11.64	4.52	9.04	0.27	0.00	0.41	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	202.55	33.13	12.56	7.56	7.41	0.61	0.91	0.30	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	197.83	25.09	11.29	6.09	10.93	0.36	0.90	0.36	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	189.79	20.80	12.91	5.88	7.75	0.29	0.14	0.29	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	176.96	29.94	11.80	6.65	9.98	0.21	0.21	0.54	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	194.72	30.98	13.05	6.64	9.74	0.22	0.66	0.00	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	205.13	18.74	13.00	4.59	9.37	0.57	0.19	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	174.87	31.58	16.12	7.27	12.11	0.28	0.37	0.47	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	294.07	38.33	15.97	7.52	15.78	0.56	0.56	0.38	1.13	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	170.00	23.89	16.19	6.10	13.27	0.40	0.13	0.40	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	222.33	36.50	14.50	6.42	9.54	0.29	0.49	0.49	0.29	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	228.20	39.72	16.42	9.74	11.08	0.38	0.95	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	167.24	24.88	11.43	7.26	9.93	0.43	0.11	0.21	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	180.80	32.80	14.30	6.45	12.05	1.12	0.00	0.56	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	191.92	36.91	14.36	6.67	11.28	0.34	0.00	0.17	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	164.10	19.87	19.14	5.47	15.50	0.00	0.55	0.18	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	189.47	31.15	13.86	6.25	11.40	0.37	0.25	0.74	0.74	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	239.76	47.55	17.60	7.12	11.42	1.21	0.40	0.13	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	209.45	21.23	8.26	5.43	12.50	0.00	0.47	0.24	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	222.62	28.97	18.25	8.93	9.92	0.99	0.20	0.40	1.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	224.26	43.50	16.84	7.25	14.26	0.70	0.47	0.00	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	201.96	20.74	10.37	6.84	8.50	0.21	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	218.78	42.91	17.92	7.08	14.82	0.66	0.44	0.44	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	216.20	30.91	17.34	8.77	16.50	0.21	0.63	0.84	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	204.97	27.99	12.38	5.79	10.90	0.40	0.00	0.27	0.67	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	211.51	40.53	19.41	10.05	19.75	0.51	0.51	1.36	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	220.36	38.17	16.39	11.37	15.23	0.00	0.96	0.39	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	232.29	22.01	8.25	6.36	8.60	0.17	0.34	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	214.26	31.27	15.64	10.01	16.19	0.69	0.41	0.82	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	246.75	41.04	11.16	8.37	11.00	0.66	0.16	0.49	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	173.67	20.28	11.42	4.94	7.84	0.17	0.00	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	232.44	35.81	12.28	6.51	9.47	0.59	0.30	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	186.59	29.59	10.13	2.67	9.06	0.00	0.27	0.27	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	173.39	21.29	15.21	4.15	6.78	0.14	0.28	0.14	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	138.58	28.33	13.10	5.24	7.38	0.00	1.43	0.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	204.97	30.84	18.34	8.26	13.10	0.81	1.41	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	129.49	15.92	15.07	4.24	7.44	0.38	0.00	0.47	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	167.00	26.20	13.97	4.54	7.69	0.70	2.10	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	187.37	30.52	22.67	5.74	11.79	0.30	0.91	0.91	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	139.64	17.50	16.64	5.39	5.87	0.24	0.24	0.12	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	459.07	64.63	42.94	8.30	21.54	2.91	1.60	0.44	1.31	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	189.22	24.95	20.69	4.26	6.08	2.43	3.65	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	146.48	20.19	16.58	4.22	7.84	0.30	0.30	0.30	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	151.32	21.71	25.11	7.92	6.79	0.68	0.45	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	230.95	36.84	35.65	8.09	12.28	2.10	0.60	0.90	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	123.98	18.54	11.57	5.67	7.91	2.36	0.47	0.47	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	123.16	19.00	19.00	7.04	12.59	1.28	0.85	0.64	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	176.09	25.84	24.64	4.81	7.21	1.20	0.60	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	46.08	3.57	4.89	1.69	1.69	0.38	0.19	0.38	0.00	0.19
Schwann Cells, donor2	11578-120F3	146.30	34.02	0.00	0.00	3.40	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	123.56	15.55	2.19	3.29	1.97	0.00	0.22	0.22	0.44	0.00
Sebocyte, donor1	11220-116B5	103.53	7.12	3.83	4.38	3.29	0.00	1.64	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	82.72	6.89	3.22	3.68	0.92	0.92	0.46	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	42.67	2.89	1.65	1.86	1.65	0.00	0.62	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	155.72	21.54	0.00	0.00	3.31	6.63	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	160.99	19.77	0.00	0.00	2.82	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	187.22	17.16	6.60	7.48	3.87	0.70	0.62	0.00	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	17.35	1.45	3.61	0.72	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	90.29	12.54	10.87	6.69	4.18	0.00	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	228.89	24.51	5.81	6.91	0.47	0.47	0.31	0.00	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	214.05	25.12	4.76	5.05	1.34	0.74	0.15	0.00	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	274.87	29.70	5.23	6.62	2.15	0.92	0.15	0.00	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	237.40	21.80	4.28	4.28	2.14	2.65	1.89	0.13	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	180.64	20.98	5.28	3.57	2.14	0.43	1.28	0.14	0.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	264.59	32.24	6.75	7.14	3.08	0.99	0.60	0.30	0.10	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	139.10	16.09	4.89	7.16	2.44	0.42	1.52	0.25	0.08	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	86.85	9.41	7.24	3.62	3.62	0.00	0.72	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	43.48	5.78	3.30	3.99	2.06	0.00	0.14	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	349.19	40.29	37.61	5.37	13.43	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	52.47	4.04	1.44	1.01	2.16	0.14	0.72	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	337.79	31.90	22.90	9.00	19.63	0.82	0.00	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	71.28	4.28	2.21	1.95	1.95	0.13	0.52	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	122.19	7.92	3.48	1.11	2.36	2.09	1.39	0.42	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	118.57	7.88	3.80	3.24	3.38	0.98	0.70	0.56	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	461.59	27.91	24.95	15.22	17.34	1.48	0.42	2.96	1.27	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	81.32	5.55	4.65	3.90	4.20	0.67	1.72	0.60	0.07	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	98.75	3.39	1.23	1.54	1.85	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	152.96	10.00	1.33	0.89	4.00	0.22	0.00	0.89	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	46.44	4.11	2.35	4.11	1.76	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	107.40	10.61	2.65	1.55	2.43	0.22	0.44	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	36.23	2.76	1.58	1.97	0.79	0.39	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	50.22	2.32	0.77	4.64	0.77	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	106.08	13.01	1.00	1.00	3.00	0.00	1.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	29.01	3.06	0.53	0.93	1.20	0.00	0.93	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	130.55	15.07	2.22	3.55	1.77	1.33	0.89	0.66	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	67.60	7.17	0.77	1.66	3.07	0.13	0.26	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	160.52	13.35	2.60	2.93	3.26	1.30	0.98	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	127.58	11.22	1.18	3.84	3.25	0.30	0.89	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	77.87	5.69	2.14	1.28	0.85	0.43	0.71	0.14	0.00	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	27.17	3.42	2.77	1.30	0.98	0.16	0.65	0.16	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	116.29	9.44	4.57	1.83	1.52	0.00	1.22	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	51.02	3.54	1.77	3.54	2.27	0.00	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	110.17	6.12	0.00	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	39.10	1.43	0.95	0.48	0.95	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	144.82	11.21	2.51	1.03	1.33	1.03	0.88	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	127.64	13.34	2.58	1.72	0.43	0.00	0.65	0.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	155.65	16.06	2.83	3.46	1.78	0.84	0.42	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	38.98	4.18	0.31	1.70	1.86	0.00	0.31	0.15	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	29.10	3.23	0.00	0.00	1.08	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	50.51	3.59	0.30	2.39	0.90	0.30	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	35.85	2.39	4.78	2.05	0.68	0.00	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	177.95	10.52	2.75	0.63	1.33	0.31	1.81	0.16	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	116.14	11.27	1.71	3.62	4.53	6.44	1.91	0.30	0.00	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	96.25	9.78	0.91	2.50	2.50	0.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	29.59	0.60	0.60	0.60	1.21	0.00	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	343.87	35.24	4.77	6.62	1.59	0.79	0.79	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	159.66	11.85	2.93	2.40	2.80	0.93	0.27	0.13	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	131.48	13.27	2.50	2.38	2.38	1.63	0.88	0.38	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	99.18	9.13	2.28	2.28	2.28	0.76	0.25	0.00	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	100.87	10.55	1.06	3.02	2.26	0.30	0.60	0.30	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	35.26	6.75	2.25	3.75	1.50	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	357.94	21.97	10.34	0.00	6.46	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	49.30	8.37	1.86	3.72	0.47	0.00	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	73.21	7.07	3.03	1.51	4.04	0.00	0.00	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	38.86	2.82	0.31	0.31	1.88	0.00	0.63	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.04	2.06	0.88	1.47	0.00	0.00	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	307.24	28.99	4.25	8.08	2.42	0.67	1.42	0.08	0.00	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	107.45	7.01	0.93	0.00	1.40	0.00	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	32.96	1.87	0.72	0.43	1.73	0.00	0.86	0.43	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	69.35	6.63	2.55	1.78	1.53	0.00	0.76	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	55.28	5.45	2.63	1.50	1.88	0.19	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	204.59	19.84	3.77	3.77	2.24	0.42	0.56	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	87.31	7.12	1.42	1.59	1.34	0.00	1.93	0.17	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	19.05	0.48	0.95	0.00	0.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	31.81	1.96	0.24	0.49	0.98	0.00	1.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	110.47	8.84	0.88	1.77	0.88	1.55	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	175.25	16.97	2.05	1.76	1.76	0.88	0.59	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	90.57	10.11	2.92	2.72	2.14	0.39	3.30	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	83.30	6.61	1.06	0.79	1.06	0.00	2.12	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	135.39	9.67	0.74	0.37	1.12	0.37	0.74	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	92.35	5.03	2.16	0.36	1.08	0.72	0.72	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	82.61	4.54	1.70	0.57	0.57	0.28	0.57	0.57	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	213.87	26.39	4.73	3.94	3.54	1.18	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	102.85	14.22	2.03	0.76	1.52	1.02	2.54	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	93.44	7.59	5.19	3.19	2.80	0.80	2.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	81.93	10.87	0.42	1.67	0.84	0.00	5.85	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	117.34	9.63	2.75	2.75	3.21	0.00	1.38	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	136.68	11.11	1.51	3.20	1.85	0.67	2.52	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	107.45	9.55	3.18	3.02	3.52	0.00	0.50	0.00	0.17	0.00
Synoviocyte, donor3	11440-118H9	77.08	3.80	1.56	0.89	1.56	0.00	0.45	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	91.12	9.29	8.22	5.00	2.14	0.00	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	51.53	1.98	5.95	1.98	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	65.99	7.87	5.09	1.62	2.55	0.00	0.46	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	80.72	5.23	2.01	2.22	1.36	0.43	1.43	0.22	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	36.34	3.48	1.55	1.16	0.77	0.39	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	43.52	4.01	1.72	2.29	1.72	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	198.32	15.13	6.77	4.55	4.06	0.86	3.44	0.37	0.12	0.12
Urethra, donor2	10319-105A4	235.59	21.58	16.19	7.19	3.60	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	21.25	1.86	0.80	1.06	1.33	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	30.44	1.60	1.60	0.40	1.20	0.00	0.80	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	23.61	1.38	1.83	1.38	0.23	0.00	0.69	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	132.40	4.24	1.56	1.78	2.23	0.00	1.11	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	195.75	32.03	8.90	0.00	22.24	2.67	0.00	1.78	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	224.45	27.16	11.44	0.00	15.73	0.00	0.00	0.00	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	148.54	13.69	7.53	3.42	13.69	0.00	2.05	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	245.86	22.38	13.77	2.41	14.81	0.00	1.38	1.38	0.69	2.75
Whole blood (ribopure), donor090325, donation2	12177-128I8	220.21	31.38	11.04	0.58	17.43	0.00	0.58	1.74	0.00	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	168.68	19.78	8.33	1.04	16.66	0.00	0.00	0.00	0.00	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	180.81	25.70	10.10	1.84	17.44	0.00	0.92	0.92	0.00	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	135.11	18.26	11.87	0.00	9.13	0.91	2.74	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	247.96	39.60	3.82	19.37	4.32	0.99	0.25	0.62	0.37	0.00
Wilms' tumor cell line:HFWT	10597-108E3	102.08	9.68	4.40	6.16	4.40	1.76	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	194.96	16.76	5.87	6.70	3.91	0.28	2.23	0.28	0.28	0.00
achilles tendon, donor2	10292-104G4	223.19	12.40	10.33	0.00	4.13	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	339.60	27.03	18.61	13.51	5.35	1.27	1.02	0.00	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	570.92	71.74	33.67	27.16	20.43	2.09	2.09	0.23	2.32	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	761.27	76.21	52.94	24.69	10.09	3.09	2.02	0.24	3.09	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	377.97	41.91	20.41	10.88	7.62	2.45	2.45	0.27	0.82	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	309.47	29.51	7.31	3.37	7.87	0.28	0.84	0.00	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	315.53	31.30	17.34	7.82	14.38	0.85	3.60	1.27	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	202.25	21.78	10.89	2.18	10.89	0.54	1.36	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	403.63	33.05	18.95	10.13	11.02	0.00	0.44	1.32	2.64	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	398.56	38.39	17.97	8.98	15.52	0.82	3.27	1.23	1.23	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	356.46	30.68	23.69	22.13	18.64	1.16	0.78	0.00	1.55	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	282.07	31.10	12.14	4.23	8.65	1.10	1.10	0.55	1.10	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	401.75	46.81	35.10	27.30	27.30	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	341.83	36.25	17.20	3.95	6.74	1.39	0.93	0.46	0.46	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	429.52	45.31	24.85	10.87	12.43	0.52	1.04	0.00	1.04	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	414.40	52.90	28.35	16.07	10.52	0.88	2.63	0.88	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	240.28	24.63	23.70	5.58	7.90	0.00	0.93	0.93	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	217.96	32.49	15.63	2.47	29.61	0.82	0.00	2.06	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	129.53	8.59	7.98	10.44	11.05	0.31	0.61	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	359.29	29.44	15.79	8.11	9.39	0.43	0.00	0.00	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	317.55	20.62	15.47	8.49	10.92	0.30	0.91	0.91	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	431.59	31.77	14.20	9.63	13.72	1.20	1.93	0.72	0.72	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	331.88	38.98	15.81	6.46	6.01	1.34	0.45	0.22	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	314.53	40.03	24.68	7.34	7.00	0.67	0.67	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	208.12	72.47	16.72	22.30	1.86	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	264.04	42.94	11.30	13.18	8.66	0.00	0.38	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	404.73	58.88	24.86	14.83	33.15	0.44	0.87	2.18	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	121.84	24.37	15.00	9.37	11.25	1.87	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	97.03	12.72	10.36	7.54	3.77	0.00	0.47	0.00	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	145.97	10.70	4.03	2.02	1.55	0.47	3.26	0.00	0.16	0.00
adipose, donor1	10184-103D4	435.70	113.76	39.29	25.22	3.52	75.06	0.59	0.00	0.00	0.00
adipose, donor2	10185-103D5	153.69	17.03	25.14	7.30	14.60	1.62	0.00	6.89	0.00	0.00
adipose, donor3	10186-103D6	257.04	41.12	20.97	14.16	13.61	10.89	1.09	3.81	0.82	0.00
adipose, donor4	10187-103D7	504.45	58.94	17.34	15.60	4.33	5.20	3.47	0.87	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	160.50	16.89	3.95	10.42	2.53	0.32	0.00	0.16	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	87.30	3.64	7.28	7.28	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	122.20	9.87	20.94	3.47	9.47	1.60	0.80	0.53	0.40	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	180.79	25.01	5.72	10.72	3.93	0.36	1.07	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	192.67	12.29	4.87	6.96	4.64	0.23	2.55	0.00	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	238.70	22.65	8.79	5.75	4.40	4.40	0.68	0.00	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	213.88	24.75	9.72	6.19	3.83	0.29	2.06	0.59	0.29	0.00
amygdala - adult, donor10196	10167-103B5	264.43	49.80	7.11	4.74	7.11	0.00	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	295.03	44.20	17.03	4.06	6.49	0.20	0.20	0.61	0.00	0.20
amygdala, newborn, donor10223	10360-105E9	161.38	24.21	8.71	2.90	10.97	0.00	0.00	1.61	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	198.38	10.95	7.26	2.80	6.24	3.31	2.16	0.51	0.25	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	278.65	20.08	7.94	4.85	3.31	0.44	0.66	0.44	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	441.26	65.14	50.77	53.11	19.04	2.00	0.33	1.00	1.00	0.00
aorta, adult, pool1	10052-101G7	166.71	18.04	5.69	3.53	3.92	0.39	0.39	0.20	0.20	0.00
appendix, adult	10189-103D9	260.43	25.23	24.06	4.66	12.03	4.27	1.16	1.16	0.39	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	187.10	24.08	11.69	10.32	7.22	2.06	0.69	1.03	1.03	0.00
artery, adult	10190-103E1	289.40	32.61	9.51	0.00	2.72	0.00	6.79	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	264.67	31.87	12.02	6.81	6.81	0.29	3.04	0.43	0.43	0.14
b cell line:RPMI1788	10427-106D4	394.06	16.80	19.03	12.64	6.25	2.97	2.53	0.00	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	140.94	11.93	1.94	2.22	2.22	1.11	0.55	1.11	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	289.66	19.55	7.84	4.76	4.27	1.69	0.40	0.00	0.30	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	144.28	7.03	7.36	3.85	1.34	0.00	3.18	0.17	0.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	212.51	11.74	13.98	2.24	15.10	0.00	1.68	0.00	2.24	0.00
bladder, adult, pool1	10011-101C2	185.45	13.91	8.04	3.80	4.89	1.09	3.15	0.87	0.00	0.11
blood, adult, pool1	10053-101G8	152.81	15.50	4.43	0.00	15.50	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	200.39	27.40	0.00	4.28	9.42	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	236.19	23.62	8.77	6.07	4.72	0.00	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	179.39	16.40	11.28	1.03	2.05	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	254.34	37.19	20.49	3.01	5.12	0.45	0.78	0.45	0.22	0.33
brain, fetal, pool1	10085-102B4	229.74	26.71	29.39	13.36	13.36	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	138.75	20.15	14.21	6.61	4.63	0.33	2.64	0.00	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	249.27	27.21	28.46	9.99	11.86	0.87	3.99	0.00	1.00	0.00
breast, adult, donor1	10080-102A8	101.02	6.31	4.42	1.26	2.53	1.26	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	165.28	11.81	6.73	5.97	2.67	1.27	0.00	0.13	0.64	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	259.75	31.54	25.36	5.26	7.11	0.62	0.93	0.62	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	203.97	17.73	1.84	3.91	2.76	0.69	1.38	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	149.37	15.25	4.84	9.68	6.29	0.24	0.48	0.73	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	319.24	23.04	38.55	10.81	7.52	0.94	0.94	0.00	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	191.85	27.56	9.52	6.89	4.27	0.55	0.98	0.33	0.44	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	226.26	28.20	32.32	7.61	8.87	1.27	0.63	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	464.21	42.59	12.78	17.57	7.19	3.19	0.00	0.80	0.27	0.00
caudate nucleus - adult, donor10196	10177-103C6	386.84	48.36	13.82	1.15	5.76	2.30	0.00	2.30	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	331.98	42.33	16.90	3.18	5.69	0.50	0.67	0.33	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	323.23	32.86	16.05	2.29	6.11	0.00	3.06	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	296.65	30.40	10.99	5.49	12.09	0.37	0.00	2.56	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	725.40	116.53	29.13	2.91	17.48	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	351.65	49.96	28.18	1.92	8.33	0.43	0.21	0.00	0.64	0.43
cerebellum, adult, pool1	10083-102B2	271.47	37.94	19.66	2.76	11.38	0.00	0.00	0.69	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	354.53	30.72	17.44	0.83	22.42	0.00	0.00	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	207.26	44.38	9.83	2.77	4.29	0.50	1.51	0.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	193.68	16.81	3.65	2.19	1.46	0.73	0.73	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	192.09	12.08	15.67	4.03	5.03	0.43	0.14	0.00	1.15	0.14
cervical cancer cell line:ME-180	10553-107I4	188.59	15.41	6.63	2.49	3.65	0.83	1.66	0.17	0.33	0.00
cervix, adult, pool1	10013-101C4	267.10	24.04	16.06	7.98	4.51	3.57	4.09	0.84	0.10	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	169.16	10.73	4.46	6.69	3.34	0.56	1.39	0.28	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	84.91	6.53	1.31	5.23	5.23	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	227.55	24.86	13.42	11.31	3.48	8.45	2.49	0.25	0.37	0.00
choriocarcinoma cell line:SCH	10785-110H2	128.63	9.24	5.05	9.24	0.99	1.60	0.62	0.25	0.25	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	91.31	6.64	12.57	6.40	3.08	1.90	0.47	0.95	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	188.62	17.38	6.27	5.13	2.56	0.57	1.14	0.57	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	197.57	15.11	4.47	2.98	3.48	6.46	1.59	0.20	0.10	0.00
chorionic membrane cells, donor3	12240-129G8	218.69	14.29	4.40	1.10	4.40	0.00	2.20	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	374.64	49.48	22.22	4.04	25.25	0.00	0.00	2.02	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	250.30	28.62	13.45	5.19	5.57	0.58	0.58	0.19	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	273.91	33.16	11.40	9.93	11.19	1.90	0.63	0.21	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	273.75	22.60	10.02	8.73	2.57	0.26	0.00	1.03	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	239.22	24.67	11.37	7.98	4.84	0.48	0.48	0.24	1.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	301.34	28.30	12.42	6.92	4.48	0.61	0.20	1.02	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	369.25	37.69	9.42	16.78	4.42	0.59	0.88	0.59	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	400.06	67.50	23.98	12.25	11.47	2.87	4.95	0.78	0.78	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	189.95	23.32	4.80	5.26	1.83	2.06	1.14	0.23	0.00	0.00
clear cell carcinoma cell line:TEN	10636-108I6	241.00	20.13	7.11	4.34	3.64	0.52	1.04	0.17	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	324.17	39.54	4.03	13.55	2.56	1.83	2.20	0.37	0.37	0.00
colon carcinoma cell line:COLO-320	10420-106C6	453.44	54.73	50.93	12.54	7.22	1.90	4.18	0.00	1.14	0.38
colon, adult, donor1	10082-102B1	113.05	4.76	8.33	2.38	2.38	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	183.66	18.80	10.11	5.64	5.52	9.87	4.11	0.24	0.00	0.24
colon, fetal, donor1	10070-101I7	170.56	18.54	11.74	2.47	3.71	0.00	0.62	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	403.35	36.67	114.59	82.50	68.75	0.00	0.00	9.17	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	275.40	50.07	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	644.20	36.97	11.47	25.07	14.02	0.85	3.40	1.70	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	334.01	24.00	10.87	15.85	7.55	32.60	3.17	0.30	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	416.27	33.56	7.47	14.24	7.19	1.69	1.97	0.71	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	363.64	30.52	41.57	7.30	7.52	1.00	1.00	0.55	0.11	0.33
cruciate ligament, donor2	10295-104G7	375.25	27.56	9.73	2.43	4.05	0.00	4.05	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	213.48	20.06	6.42	7.22	3.21	0.00	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	225.35	23.52	19.68	2.88	4.08	0.96	0.00	0.48	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	431.90	42.48	34.90	9.41	21.58	1.61	0.92	1.15	0.46	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	211.05	16.93	6.92	3.33	4.62	0.51	0.51	0.26	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	148.28	15.89	6.50	3.37	1.93	1.20	1.44	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	201.83	21.93	14.95	1.50	3.99	0.00	2.49	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	275.08	17.28	7.20	0.00	5.76	1.44	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	307.50	36.78	19.13	2.94	6.62	1.47	0.74	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	339.02	23.04	22.71	10.65	12.31	1.40	2.40	0.74	0.58	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	170.77	23.54	14.88	15.77	10.88	12.88	0.44	1.78	0.67	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	296.90	32.81	4.59	13.18	3.44	5.30	0.14	0.43	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	80.16	18.50	5.55	2.47	3.70	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	105.95	8.78	4.84	0.91	1.82	0.61	0.00	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	105.28	10.81	2.78	4.94	3.70	0.62	0.62	0.31	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	98.51	10.51	6.57	3.94	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	112.63	12.74	1.34	7.71	2.68	0.34	3.69	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	203.35	15.41	8.52	7.79	4.71	0.72	2.90	0.36	0.36	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	151.97	17.21	2.89	2.57	2.89	1.29	0.64	0.16	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	261.11	28.23	8.78	5.22	3.78	2.33	1.00	0.44	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	243.95	26.62	8.47	4.73	3.85	0.66	0.77	0.00	0.33	0.00
epididymis, adult	10197-103E8	257.03	24.28	25.75	7.95	6.91	2.51	2.09	0.63	0.21	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	139.98	10.64	3.37	7.10	2.13	0.71	2.13	0.00	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	161.23	12.58	3.15	5.11	4.33	0.00	3.93	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	249.13	21.49	8.91	5.90	5.37	0.26	0.26	0.13	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	271.25	19.39	10.83	11.81	10.04	0.20	0.10	0.79	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	243.78	19.38	9.41	7.28	6.61	0.45	0.11	0.11	0.34	0.00
esophagus, adult, pool1	10015-101C6	154.49	13.70	7.86	2.87	2.65	1.38	2.97	0.21	0.21	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	348.41	25.92	5.64	30.06	5.76	2.63	2.88	0.38	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	400.82	55.54	24.15	2.41	9.66	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	241.98	33.67	6.31	0.00	2.10	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	160.73	19.35	7.44	1.49	2.98	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	232.74	18.34	17.20	1.15	2.29	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	164.69	36.43	26.23	0.00	10.20	1.46	1.46	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	139.07	18.81	8.90	2.80	3.81	0.76	0.76	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	175.92	22.44	8.21	7.95	2.31	0.38	0.13	0.13	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	182.10	23.03	3.09	7.83	2.14	0.71	1.42	0.47	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	321.35	45.13	24.86	5.07	9.01	1.22	0.38	1.03	0.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	226.69	24.02	7.51	6.00	5.70	2.10	2.70	0.30	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	181.41	19.93	4.11	6.49	4.39	0.37	0.55	0.46	0.27	0.00
gall bladder, adult	10198-103E9	174.56	16.42	10.62	5.07	6.76	0.24	0.97	0.00	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	471.90	44.02	23.62	2.15	49.93	0.54	0.00	4.29	0.00	2.15
gamma delta positive T cells, donor2	11938-126A3	481.80	56.77	15.31	1.49	63.87	0.75	2.61	4.86	0.00	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	225.58	27.67	8.24	4.65	3.80	1.06	0.21	0.00	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	116.63	9.28	1.74	3.87	1.35	0.00	0.97	0.39	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	387.59	35.25	12.46	21.97	6.89	1.31	2.62	0.33	0.66	0.00
gastric cancer cell line:GSS	10560-108A2	295.62	19.22	4.58	16.47	2.75	1.83	8.24	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	398.20	54.14	15.76	8.00	4.80	4.34	0.23	0.69	1.14	0.23
giant cell carcinoma cell line:LU65	10487-107B1	184.50	15.60	6.88	5.85	1.72	0.57	1.49	0.11	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	341.36	23.93	8.26	4.90	0.98	1.54	0.70	0.14	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	198.29	18.96	8.73	5.99	4.99	0.75	1.75	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	279.50	26.81	6.76	6.86	4.96	0.21	0.53	0.11	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	249.00	20.36	6.46	8.15	4.07	0.84	1.26	0.00	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	225.16	20.31	5.19	5.85	4.64	0.55	0.66	0.00	0.11	0.11
glioma cell line:GI-1	10413-106B8	251.00	22.84	5.56	7.32	4.98	5.56	2.64	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	416.21	48.84	24.05	3.64	4.37	0.73	0.00	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	611.95	68.59	44.43	8.30	5.86	1.71	0.00	0.24	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	328.61	61.61	58.88	2.74	2.74	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	220.63	26.11	8.53	4.80	6.40	1.07	0.53	2.66	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	345.05	22.02	78.31	95.44	97.89	0.00	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	196.71	0.00	10.93	0.00	32.79	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	120.21	10.45	10.45	5.23	0.00	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	203.52	24.64	6.08	4.48	6.08	0.32	0.00	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	293.37	41.78	10.10	6.89	1.38	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	271.16	36.58	9.60	10.97	1.83	2.74	0.00	0.46	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	270.52	34.14	9.02	5.15	0.64	1.29	0.00	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	117.86	50.31	14.37	0.00	2.87	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	342.25	38.41	10.97	7.54	2.06	0.00	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	253.80	35.31	8.83	4.41	4.41	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	252.00	22.99	14.65	12.64	11.21	1.15	0.57	1.15	0.00	0.00
heart - mitral valve, adult	10205-103F7	282.52	27.51	9.57	3.29	3.29	1.20	1.49	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	248.40	32.95	10.98	2.61	2.88	0.78	1.57	0.26	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	301.42	22.48	5.83	10.82	4.16	0.00	4.16	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	136.51	19.59	6.73	6.12	2.45	1.84	0.20	0.61	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	87.30	13.63	3.83	0.43	0.85	0.85	0.43	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	105.10	9.66	1.38	2.99	1.38	0.69	5.98	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	282.68	30.50	16.84	5.96	3.18	0.41	2.36	0.21	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	94.41	7.40	0.62	2.16	2.78	0.62	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	186.70	21.41	7.14	13.08	5.95	1.19	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	353.03	55.14	6.52	29.28	6.30	1.33	0.99	0.44	0.44	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	398.35	63.48	7.65	32.77	4.49	1.34	0.49	0.24	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	389.56	59.02	9.20	31.53	6.27	1.62	0.81	0.30	0.61	0.10
hepatoma cell line:Li-7	10484-107A7	250.24	18.80	6.67	6.78	1.45	1.22	0.78	0.00	0.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	311.05	29.15	16.98	8.74	6.83	0.80	0.10	0.80	1.31	0.00
hippocampus - adult, donor10196	10169-103B7	324.59	36.91	11.36	2.84	6.62	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	320.23	39.60	21.43	4.08	4.69	0.82	1.02	0.61	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	238.52	39.34	10.95	0.00	6.97	0.50	0.00	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	194.57	29.96	15.51	3.88	8.46	0.35	0.35	2.47	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	648.80	102.54	28.08	14.04	1.83	8.54	0.61	1.22	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	381.32	43.20	22.97	12.76	1.37	2.36	0.79	0.20	0.98	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	436.19	48.24	23.61	11.17	1.52	3.05	1.27	1.02	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	269.53	34.96	33.83	15.22	2.82	14.66	1.69	0.56	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	292.04	48.54	35.37	16.01	4.91	32.28	2.07	1.29	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	377.33	41.38	36.82	15.18	1.14	22.78	1.14	0.38	1.90	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	401.44	52.55	19.85	21.90	12.55	11.68	1.46	4.09	0.29	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	342.10	40.50	34.47	27.79	13.79	9.48	1.51	2.80	1.51	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	354.10	38.79	18.77	20.44	8.34	8.76	0.42	0.83	1.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	495.13	56.12	13.97	26.52	11.13	23.92	0.95	3.55	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	414.33	51.91	15.75	28.29	13.66	9.80	0.96	2.57	0.96	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	445.73	51.17	11.45	16.83	7.41	24.91	0.67	1.35	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	317.66	36.15	17.84	15.49	2.97	3.76	1.41	0.31	1.25	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	317.87	43.73	17.69	8.35	1.97	4.91	1.47	0.00	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	624.89	88.15	26.18	10.47	2.62	12.22	2.62	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	316.15	44.29	36.46	30.35	3.63	24.82	1.53	0.38	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	272.11	34.01	33.14	30.96	2.18	17.01	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	310.35	72.47	31.98	28.49	3.00	37.98	1.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	209.87	18.65	31.84	14.51	16.77	10.93	0.75	5.65	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	219.17	22.28	21.83	14.10	12.73	9.55	0.00	5.00	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	228.04	25.69	31.01	11.90	18.79	6.58	0.94	5.64	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	279.74	30.70	19.60	17.64	11.59	9.14	0.82	2.61	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	241.83	31.93	21.19	15.10	10.16	9.29	0.00	6.10	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	268.13	38.86	18.23	16.44	16.44	5.68	0.30	2.99	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	406.99	50.44	21.80	19.21	2.40	2.22	0.37	0.74	0.74	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	323.80	38.80	21.97	15.98	2.28	3.14	0.57	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	527.95	84.11	22.05	16.74	4.90	6.53	2.45	0.00	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	266.17	35.21	22.18	22.89	3.52	23.59	0.35	1.76	1.06	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	228.37	25.66	20.27	18.37	3.48	13.30	0.32	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	269.33	31.17	23.00	19.67	3.33	19.37	1.21	0.30	1.21	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	268.39	33.61	16.55	15.00	12.41	7.24	0.52	4.65	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	285.59	29.22	17.93	15.94	15.28	9.30	0.66	3.98	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	341.44	48.23	12.57	16.93	9.24	8.21	0.26	2.31	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	326.21	45.76	8.44	19.17	11.76	9.71	0.51	2.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	439.95	54.52	15.90	22.72	16.66	9.09	0.76	0.76	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	387.47	45.37	8.74	14.11	12.43	10.42	0.34	3.02	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	356.46	36.95	23.43	16.18	2.42	4.59	0.48	1.21	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	515.63	66.85	29.41	21.39	4.90	4.90	0.89	0.89	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	371.22	52.20	20.49	14.15	3.41	4.88	0.49	0.49	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	229.52	33.62	34.23	23.84	2.14	14.36	0.31	0.00	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1642.89	406.66	52.05	9.76	3.25	292.79	6.51	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	353.12	60.23	24.49	20.85	3.97	27.47	0.66	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	320.17	43.78	25.72	16.42	16.42	8.21	1.09	4.38	1.64	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	313.75	32.93	22.07	19.18	18.82	11.22	0.72	4.34	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	325.27	35.94	18.51	18.51	13.17	9.61	0.71	6.05	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	354.43	40.58	20.29	13.13	10.74	14.32	0.00	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	477.51	48.89	19.64	20.58	15.71	28.03	0.68	3.52	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	358.56	46.07	14.01	14.82	10.24	9.70	0.54	2.69	1.08	0.00
immature langerhans cells, donor1	11904-125F5	417.70	41.65	14.04	11.38	17.68	0.97	2.42	0.97	0.24	0.00
immature langerhans cells, donor2	11905-125F6	434.09	20.60	15.05	15.05	16.63	0.00	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	271.22	37.00	25.83	5.30	11.26	1.32	0.76	1.23	0.28	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	106.32	6.83	7.80	4.55	4.88	0.00	0.33	0.00	0.65	0.00
kidney, adult, pool1	10017-101C8	168.51	16.22	6.31	3.10	5.31	1.10	3.80	0.70	0.20	0.10
kidney, fetal, pool1	10045-101F9	174.79	15.99	17.97	6.30	2.97	0.14	1.63	0.71	0.35	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	312.87	24.29	4.40	6.25	6.25	3.83	2.13	1.14	0.14	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	122.90	10.23	6.50	1.38	1.94	0.00	2.35	0.14	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	97.62	8.07	7.89	3.12	2.57	0.00	0.55	0.00	0.00	0.18
left atrium, adult, donor1	10079-102A7	110.06	15.80	2.72	1.63	1.63	0.00	1.09	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	97.59	11.63	1.01	1.01	1.01	0.00	1.52	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	211.77	25.45	4.65	9.58	2.19	0.27	0.27	0.00	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	50.29	5.03	1.44	0.72	0.72	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	57.07	7.61	0.54	2.17	1.09	0.00	0.54	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	110.24	9.71	1.21	1.70	1.94	0.97	0.00	0.24	0.24	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	177.78	0.00	0.00	6.35	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	147.42	29.28	5.23	9.41	8.36	5.23	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	186.30	30.22	8.15	3.54	2.60	1.42	0.35	0.35	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	140.90	13.43	3.91	2.97	2.81	0.47	0.00	0.16	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	147.67	27.78	7.80	6.58	8.77	0.85	0.00	0.24	0.00	0.00
liver, adult, pool1	10018-101C9	125.92	11.02	4.86	6.16	3.40	0.16	4.70	0.00	0.00	0.00
liver, fetal, pool1	10086-102B5	76.20	2.82	2.82	10.35	1.88	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	466.64	46.08	21.87	3.06	5.98	0.73	0.58	0.73	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	329.05	31.19	19.38	4.98	4.80	0.74	0.00	0.00	0.18	0.18
locus coeruleus, adult, donor10258	10375-105G6	169.85	16.36	10.16	3.39	4.51	0.85	0.00	1.41	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	346.59	24.40	10.94	2.94	5.47	1.68	0.00	1.26	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	114.04	5.40	4.01	4.01	2.35	0.28	0.83	0.00	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	132.37	12.41	4.14	2.76	5.52	0.00	4.14	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	197.46	31.64	9.10	12.52	9.75	0.26	0.53	0.40	0.53	0.00
lung, adult, pool1	10019-101D1	201.88	13.94	5.67	5.32	5.67	1.65	4.13	0.47	0.00	0.12
lung, fetal, donor1	10068-101I5	561.40	45.67	18.84	3.42	7.42	0.86	0.00	0.57	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	198.87	11.00	6.87	4.58	2.75	3.21	1.37	0.00	0.00	0.92
lymph node, adult, donor1	10077-102A5	195.97	10.41	7.10	2.84	12.31	0.00	1.42	0.47	0.00	0.95
lymphangiectasia cell line:DS-1	10727-110A7	220.49	18.63	11.84	4.16	8.55	0.44	0.66	0.88	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	248.58	19.47	5.43	6.79	15.39	1.06	1.06	0.75	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	299.87	15.29	6.80	1.70	5.10	5.10	0.85	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	166.94	8.88	5.77	1.78	2.22	4.44	0.89	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	155.23	8.92	2.91	1.04	2.70	2.70	1.66	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	197.95	8.06	2.61	4.03	0.47	4.50	0.95	0.24	0.00	0.00
mature adipocyte, donor4	12234-129G2	296.65	25.80	7.90	4.74	3.95	3.69	1.05	0.00	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	231.35	22.63	16.44	12.15	9.53	2.38	0.48	0.48	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	351.95	69.94	14.66	5.64	13.54	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	337.10	44.32	15.82	3.49	6.07	1.47	0.18	0.37	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	192.52	37.17	13.03	3.18	6.99	0.32	0.00	1.91	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	360.38	87.00	16.63	3.41	5.97	1.71	0.85	1.71	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	511.99	89.27	26.49	4.56	13.33	1.35	0.17	1.18	0.17	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	373.73	53.69	22.07	4.88	7.43	1.70	0.21	0.42	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	130.99	25.04	19.26	0.00	7.71	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	2239.16	631.56	14.35	14.35	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	223.61	38.76	16.51	3.95	16.51	0.36	0.36	4.31	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	329.68	25.31	16.22	1.30	11.68	1.30	1.95	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	307.29	28.64	21.98	4.95	3.56	0.00	0.15	0.31	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	255.09	19.92	21.47	4.73	6.78	0.57	0.73	0.73	0.41	0.16
medulla oblongata, newborn, donor10223	10361-105F1	177.76	14.23	6.94	5.21	5.21	0.35	0.35	1.39	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	939.45	110.48	84.36	29.23	6.20	2.21	1.55	0.44	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	134.74	21.28	8.80	4.65	1.83	0.49	0.12	0.24	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	149.06	9.63	3.45	3.74	4.60	2.44	0.43	0.14	0.14	0.14
melanoma cell line:G-361	10465-106H6	133.29	11.40	4.89	7.87	2.99	2.71	0.27	0.00	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	152.14	9.95	5.43	2.53	3.62	0.36	1.45	0.18	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	681.13	141.87	39.65	59.92	14.10	2.64	0.00	3.52	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	546.70	115.61	54.18	26.18	15.81	3.89	0.26	0.26	2.07	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	187.80	26.08	1.99	6.14	1.69	0.46	0.92	0.31	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	156.15	15.45	3.27	4.18	1.09	0.36	1.27	0.00	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	121.33	16.15	3.73	1.66	0.83	0.41	0.41	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	107.88	9.13	2.95	1.55	0.98	0.14	1.12	0.14	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	126.52	8.47	2.70	3.47	1.73	0.19	0.39	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	108.28	5.55	0.00	1.39	2.08	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	65.74	4.12	1.20	2.06	0.86	0.00	0.34	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	112.72	11.62	3.45	2.65	1.50	0.23	0.69	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	181.18	19.10	3.18	4.11	2.39	0.53	0.40	0.00	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	142.74	18.91	2.97	3.38	2.16	0.27	0.14	0.14	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	167.44	16.64	2.99	1.71	2.42	0.14	0.28	0.00	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	97.82	12.52	1.32	3.62	1.98	0.33	0.99	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	145.43	16.19	3.18	3.04	2.63	0.14	0.55	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	172.80	20.60	2.79	1.05	2.44	0.35	0.70	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	110.04	12.25	1.43	1.84	1.63	0.00	0.82	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	126.53	14.38	2.52	1.44	3.59	0.72	1.08	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	89.69	7.14	1.24	1.34	1.14	0.10	0.41	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	83.44	5.70	0.91	0.00	2.51	0.46	0.23	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	248.38	18.88	2.52	1.68	0.84	0.42	0.84	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	137.78	15.24	2.39	1.94	1.64	0.30	0.30	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	120.53	10.15	2.01	2.01	2.01	0.26	0.96	0.09	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	135.11	10.31	2.21	0.74	2.95	0.00	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	141.08	10.87	2.00	2.29	2.00	0.57	0.57	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	396.17	51.36	4.63	8.00	8.84	1.26	0.84	0.00	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	113.25	8.68	3.20	1.83	2.28	0.46	1.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	132.24	10.23	1.53	1.28	2.30	0.77	0.51	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	145.27	12.56	2.62	2.36	2.36	0.26	0.26	0.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	155.58	13.56	3.39	2.16	2.77	0.62	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	136.74	12.24	1.88	1.65	3.53	0.71	0.24	0.24	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	142.49	10.83	3.72	1.69	2.71	0.34	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	148.94	13.36	3.54	1.18	2.75	0.39	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	144.11	9.73	3.24	1.39	0.46	0.00	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	181.13	17.02	6.06	1.73	2.88	1.15	0.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	136.54	9.59	2.01	1.12	2.01	0.89	0.22	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	147.82	11.30	3.12	2.16	2.64	0.72	0.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	190.67	16.87	7.33	2.20	2.20	0.73	1.47	0.73	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	135.61	10.07	3.02	2.69	3.69	0.67	0.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	151.06	11.46	3.68	2.87	2.05	0.41	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	153.35	15.03	1.72	1.72	5.58	0.86	0.43	0.43	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	112.11	21.88	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	134.29	0.00	0.00	0.00	10.33	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	147.13	15.59	2.27	2.27	3.57	0.97	0.97	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	133.86	16.00	1.45	1.45	1.45	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	147.66	11.19	3.20	4.80	1.60	0.53	1.07	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	134.93	12.27	0.82	2.45	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	128.28	10.11	1.55	3.89	4.28	0.78	0.00	1.17	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	117.53	12.59	0.00	2.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	138.09	12.92	1.99	1.99	2.98	0.99	0.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	147.78	23.84	0.00	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	142.90	11.86	1.19	2.37	3.56	0.00	0.00	1.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	145.00	8.53	4.87	1.22	6.09	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	131.74	8.23	4.43	1.27	1.90	0.00	0.00	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	119.68	13.11	2.41	2.41	1.72	0.00	1.03	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	150.44	12.90	0.00	0.00	6.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	103.79	11.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	10.33	6.89	6.89	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	77.42	5.70	2.44	2.04	2.85	0.41	0.81	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	73.88	9.53	0.79	1.59	3.18	0.00	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	59.54	5.31	0.59	1.18	1.77	0.59	2.95	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	59.22	2.81	4.36	0.94	2.18	0.00	1.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	56.14	5.35	2.67	0.00	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	120.63	10.64	3.55	4.73	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	166.92	5.14	0.00	0.00	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	118.40	13.77	1.38	3.44	0.00	0.00	2.07	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	109.35	5.94	1.98	0.49	1.98	0.00	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	78.51	2.24	0.00	1.12	1.12	0.00	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	85.87	9.54	1.91	1.27	0.64	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	60.85	4.03	0.00	1.21	0.40	0.00	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	69.78	0.00	0.00	6.54	4.36	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	31.68	6.34	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	109.24	4.86	2.43	3.64	1.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	180.76	0.00	9.04	9.04	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	146.62	4.12	0.82	4.94	0.00	2.47	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	101.00	8.73	0.99	1.79	0.99	0.20	2.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	105.46	7.46	1.95	1.95	1.30	0.00	2.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	104.92	7.13	2.04	3.06	7.13	1.02	2.04	1.02	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	153.20	11.61	2.32	3.09	7.74	0.00	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	107.02	5.20	1.89	2.83	1.89	0.00	1.18	0.24	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	201.32	19.69	3.71	9.96	3.01	0.46	0.70	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	243.59	34.19	0.00	0.00	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	171.70	16.03	2.88	1.75	3.39	0.92	0.21	0.10	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	87.83	11.35	6.58	4.99	3.63	0.00	0.00	0.23	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	184.09	22.00	4.65	2.69	0.98	0.73	0.98	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	152.57	16.61	2.44	3.99	3.32	0.00	0.00	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	255.45	25.75	6.83	6.83	6.04	0.00	0.53	0.53	0.53	0.00
mesothelioma cell line:Mero-83	10854-111F8	189.46	23.66	4.43	2.89	4.94	0.51	0.34	0.51	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	74.32	9.10	1.52	1.26	0.51	0.51	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	150.11	18.63	7.25	3.31	6.21	0.41	0.83	0.41	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	208.72	24.68	4.47	5.63	5.14	0.00	0.50	0.33	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	186.60	22.62	2.90	4.52	4.71	0.00	1.27	0.36	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	119.06	13.15	5.12	5.12	4.10	0.00	0.85	0.51	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	167.95	12.98	4.83	5.34	1.53	0.76	0.25	0.00	0.76	0.00
mesothelioma cell line:No36	10857-111G2	160.17	20.88	5.55	5.55	1.63	0.33	0.33	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	104.59	14.90	2.17	1.63	1.35	0.27	0.00	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	464.45	38.77	7.48	1.92	7.10	0.96	0.00	0.77	0.19	0.19
migratory langerhans cells, donor2	11902-125F3	209.79	17.22	4.52	1.59	3.79	0.85	0.37	0.49	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	260.25	22.44	7.72	1.26	10.77	1.44	0.90	1.26	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	125.37	10.77	5.22	2.61	7.84	0.33	1.31	0.33	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	80.54	20.13	2.97	4.45	4.45	0.21	0.21	0.00	0.64	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	196.73	19.12	6.68	4.15	4.38	0.92	0.46	0.46	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	175.45	16.56	7.42	6.66	6.47	0.95	1.71	0.00	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	388.62	23.84	14.97	8.87	8.69	0.74	1.85	0.18	0.74	0.00
myeloma cell line:PCM6	10474-106I6	114.25	7.71	7.31	4.94	9.29	0.79	2.77	0.40	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	170.96	25.36	8.62	3.55	5.58	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	185.35	24.13	11.38	5.88	4.90	0.78	0.20	0.20	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	64.18	3.34	2.23	2.34	0.78	0.00	1.56	0.33	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	82.14	3.09	2.06	1.76	1.25	0.29	2.21	0.07	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	192.64	8.28	3.86	3.31	3.31	0.55	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	551.69	51.53	40.72	26.23	12.19	3.22	1.84	0.23	2.07	0.00
neuroblastoma cell line:NB-1	10539-107G8	558.64	74.46	23.76	17.59	5.80	3.74	0.75	0.00	0.37	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	187.06	25.52	28.05	4.64	6.75	6.12	0.84	0.00	2.53	0.00
neuroblastoma cell line:NH-12	10555-107I6	706.46	77.34	61.87	11.74	5.22	3.54	0.56	0.37	2.42	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	628.41	69.74	92.28	9.96	23.49	4.27	1.19	1.19	1.90	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	346.85	39.28	44.19	9.98	12.67	7.29	2.53	0.79	0.95	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	268.68	28.58	9.06	11.27	4.23	0.40	0.60	0.00	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	193.27	19.07	23.52	6.99	7.63	1.27	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	158.90	14.64	1.86	3.46	3.99	0.27	0.27	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	14.87	14.87	0.00	29.75	0.00	0.00	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	132.81	26.56	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00	18.94	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	689.00	72.05	104.01	23.00	9.13	2.37	1.52	1.01	1.86	0.85
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	356.23	61.64	11.21	7.20	5.60	2.40	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	150.36	13.14	4.49	7.37	2.89	0.00	0.32	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	163.44	19.71	3.15	2.89	1.31	0.26	1.05	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	302.50	37.78	22.50	5.06	9.66	1.22	0.66	0.84	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	513.04	72.11	18.54	4.12	12.36	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	482.79	75.95	36.23	5.90	7.51	1.34	0.00	0.00	0.00	0.54
occipital cortex, newborn, donor10223	10355-105E4	279.14	57.50	17.83	4.37	15.29	0.73	0.00	4.00	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	354.50	37.52	17.84	3.67	9.45	3.15	0.00	1.57	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	574.99	65.22	52.35	11.59	32.61	3.86	0.86	1.29	0.43	0.00
occipital pole, adult, pool1	10036-101E9	134.90	18.13	19.00	3.31	7.25	0.47	0.47	0.71	0.08	0.24
olfactory region, adult	10195-103E6	321.35	47.76	27.13	3.44	8.02	0.76	0.19	0.38	0.00	0.19
optic nerve, donor1	10277-104E7	670.35	72.04	60.03	4.00	6.00	2.00	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	164.94	14.35	8.66	6.15	2.96	1.71	1.14	0.00	0.57	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	315.58	30.09	15.94	6.46	3.71	0.69	1.51	0.41	1.10	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	244.50	32.00	4.57	3.05	1.19	1.02	0.34	0.17	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	202.83	24.60	8.20	6.12	1.50	0.92	0.12	0.23	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	173.15	17.05	5.59	4.41	3.23	0.88	0.00	0.88	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	161.64	20.56	5.61	9.34	5.61	1.87	0.93	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	222.24	16.33	7.63	6.36	2.76	1.91	1.27	0.00	1.06	0.00
ovary, adult, pool1	10020-101D2	270.62	20.70	15.11	3.84	3.84	1.22	4.37	0.00	0.00	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	117.51	15.40	4.22	3.12	8.07	0.73	0.37	0.18	0.00	0.00
pancreas, adult, donor1	10049-101G4	108.17	10.35	3.76	5.64	0.94	0.00	3.76	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	137.25	12.58	8.95	16.49	3.07	1.68	1.68	0.56	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	235.60	25.55	6.47	2.90	5.96	0.34	0.51	0.68	0.17	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	196.71	20.37	13.25	7.95	5.80	1.66	1.82	0.33	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	270.91	33.22	21.87	4.76	10.16	0.73	0.18	1.28	0.55	0.46
parietal cortex, adult, donor10258	10373-105G4	316.36	35.23	12.48	2.94	5.87	0.00	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	396.88	49.85	35.74	0.94	6.58	0.00	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	358.86	48.17	21.95	4.28	4.56	0.57	0.29	0.29	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	225.94	26.96	20.62	4.93	6.52	0.44	0.70	0.97	0.26	0.26
parietal lobe, fetal, donor1	10072-101I9	600.33	85.35	40.73	7.76	24.25	2.91	0.00	2.91	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	284.13	48.98	10.84	5.23	14.58	0.75	0.75	1.87	0.00	0.37
parotid gland, adult	10199-103F1	172.67	11.72	3.08	2.47	4.32	0.00	2.47	0.00	0.00	0.00
penis, adult	10200-103F2	248.68	28.47	10.74	3.76	5.91	1.61	2.69	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	392.70	5.02	7.81	1.30	3.53	2.79	1.12	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	127.63	9.03	4.52	1.89	1.46	0.15	0.44	0.00	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	239.95	64.50	20.64	5.81	8.39	0.65	0.00	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	184.18	44.42	8.88	2.37	11.84	0.59	1.18	2.37	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	201.92	38.25	5.02	0.00	9.41	0.63	1.88	3.14	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	395.61	43.51	13.15	9.11	8.09	0.00	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	367.43	42.22	15.11	7.30	7.30	1.04	1.04	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	314.11	27.24	17.02	3.40	5.11	0.85	4.26	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	191.03	21.50	6.77	3.01	4.52	0.65	1.72	0.32	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	343.25	18.54	13.11	12.05	5.03	0.40	1.72	0.79	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	165.13	18.21	3.89	3.42	1.25	0.31	0.00	0.00	0.00	0.00
pons, adult, pool1	10033-101E6	289.53	27.20	20.57	4.56	8.18	0.95	0.52	1.46	0.34	0.26
postcentral gyrus, adult, pool1	10032-101E5	197.63	27.90	21.97	3.49	7.76	0.70	0.26	0.78	0.17	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	207.05	10.46	27.19	37.65	87.84	0.00	0.00	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	214.81	22.03	0.00	11.02	16.52	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	93.89	23.47	35.21	11.74	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	166.49	12.53	3.93	9.32	3.06	0.44	0.87	0.29	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	209.63	21.05	8.71	6.53	8.17	0.36	2.54	0.18	0.00	0.00
prostate, adult, pool1	10022-101D4	170.86	16.14	7.53	3.45	2.90	0.54	3.17	0.27	0.09	0.36
putamen, adult, donor10196	10176-103C5	464.81	58.31	30.45	3.07	13.22	1.65	0.00	0.47	0.24	0.00
putamen, adult, donor10252	10152-102I8	390.18	54.90	9.80	9.80	9.80	0.00	1.96	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	157.36	26.23	10.93	5.46	5.46	0.00	0.00	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	273.02	40.35	14.74	1.69	4.35	0.72	1.21	0.72	0.24	0.24
putamen, newborn, donor10223	10365-105F5	359.09	34.48	12.74	1.50	4.50	0.75	2.25	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	182.13	10.47	2.62	2.62	4.36	0.87	2.62	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	491.02	38.95	16.69	12.52	6.95	2.78	2.78	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	122.54	13.57	4.24	2.54	2.54	0.85	0.85	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	170.24	8.70	12.84	8.28	5.38	0.00	0.00	0.41	1.24	0.00
retina, adult, pool1	10030-101E3	165.30	21.07	17.79	3.78	5.27	0.89	1.29	0.70	0.60	0.40
retinoblastoma cell line:Y79	10475-106I7	392.82	56.38	26.50	28.58	2.60	2.60	1.30	0.78	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	222.41	33.07	4.79	10.94	6.27	1.11	0.00	0.25	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	647.32	48.09	10.12	12.37	3.94	1.12	1.69	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	114.44	9.85	3.79	1.52	4.55	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	110.22	9.06	6.96	6.47	2.59	1.62	1.78	0.16	0.16	0.00
salivary acinar cells, donor2	11772-123I8	134.11	13.08	12.25	7.02	3.58	0.96	2.75	0.83	0.28	0.00
salivary acinar cells, donor3	11773-123I9	62.89	7.94	19.20	7.28	5.96	0.00	1.32	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	137.27	12.01	4.00	1.14	4.58	0.00	0.00	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	145.61	11.97	2.87	2.53	4.22	0.42	2.11	0.34	0.34	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	125.43	9.29	3.76	3.29	3.88	0.47	1.88	0.00	0.12	0.00
seminal vesicle, adult	10201-103F3	246.55	29.10	11.64	1.06	6.88	2.12	1.59	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	138.71	24.29	5.83	9.72	1.46	0.73	0.24	0.24	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	125.06	14.59	6.29	0.75	1.51	0.25	0.25	0.75	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	180.64	23.08	6.02	3.01	4.01	0.00	1.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	202.02	30.63	13.84	6.45	2.28	0.67	0.94	0.13	1.07	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	231.45	23.32	11.83	3.65	4.75	1.55	1.11	0.44	0.77	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	263.47	25.29	8.90	6.58	3.87	1.42	1.94	0.26	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	337.64	51.07	13.48	5.67	8.51	2.13	2.84	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	238.68	15.95	6.12	3.72	2.04	1.80	11.15	0.36	0.24	0.24
skeletal muscle, fetal, donor1	10066-101I3	151.76	5.03	3.02	1.01	0.00	0.00	1.01	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	122.13	6.79	20.36	0.00	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	253.12	29.04	15.15	8.21	9.47	1.26	0.00	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	280.16	34.69	35.02	20.34	10.34	2.00	0.33	1.00	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	376.99	86.05	24.59	20.80	5.04	1.89	0.32	1.26	1.58	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	300.30	29.30	18.70	19.27	4.63	0.58	2.12	0.58	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	443.71	50.27	32.64	9.23	5.77	1.98	1.32	0.16	0.99	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	509.25	36.35	55.65	6.11	3.86	1.93	1.29	0.48	0.48	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	133.15	36.17	32.91	13.95	20.92	1.31	0.22	1.96	1.31	0.22
small intestine, adult, pool1	10024-101D6	206.28	24.01	11.11	7.29	5.26	1.67	6.21	0.36	0.00	0.12
small intestine, fetal, donor1	10064-101I1	223.83	24.08	9.09	6.14	3.69	0.25	0.49	0.00	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	234.40	45.65	10.26	4.62	5.64	2.56	0.51	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	230.80	29.21	10.60	3.36	4.14	0.00	0.52	0.52	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	94.34	21.44	10.99	5.63	3.75	0.00	0.27	0.00	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	446.88	45.19	20.65	5.05	6.19	0.46	0.69	0.23	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	424.24	29.57	26.42	4.34	6.70	0.79	0.39	0.39	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	369.42	31.13	11.76	3.46	2.77	0.69	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	337.24	42.08	15.86	7.93	4.27	4.27	0.61	0.61	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	244.76	38.11	4.59	3.21	5.51	0.92	1.38	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	140.09	16.88	3.73	3.73	5.53	0.30	0.30	0.15	0.00	0.00
spleen, adult, pool1	10025-101D7	198.90	13.88	8.48	3.74	11.34	1.10	2.86	0.77	0.11	0.44
spleen, fetal, pool1	10044-101F8	149.30	12.47	12.63	5.96	7.95	0.48	0.87	0.32	0.16	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	271.00	19.15	12.42	6.62	4.97	1.45	0.93	0.21	0.62	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	99.12	7.41	2.28	1.52	0.76	0.19	1.90	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	258.59	33.20	11.88	8.39	4.19	2.45	0.35	0.35	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	167.32	15.64	3.52	2.74	4.30	0.39	0.78	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	276.67	29.83	21.16	3.38	9.57	1.13	1.13	0.56	1.69	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	102.94	10.59	4.66	2.12	1.27	0.42	2.97	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	170.50	12.69	3.81	5.08	1.69	0.00	3.38	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	341.75	29.90	17.09	17.09	5.34	1.07	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	209.07	17.66	13.10	3.99	8.55	1.14	5.13	1.14	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	1519.68	108.55	54.27	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	467.96	45.90	44.24	11.63	9.14	0.83	0.42	0.42	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	230.18	25.35	12.93	2.07	4.14	0.00	0.00	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	168.87	18.37	6.36	3.53	3.53	2.12	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	396.40	37.83	20.40	14.21	10.55	2.06	1.83	0.00	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	161.15	22.29	22.21	5.00	9.07	0.76	0.59	0.85	0.25	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	445.88	70.51	52.00	7.83	38.46	4.27	0.71	2.85	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	414.48	61.54	53.18	12.31	28.13	0.44	0.44	0.44	0.44	0.44
tenocyte, donor1	11763-123H8	148.72	11.52	2.79	1.75	2.09	0.00	0.35	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	86.22	7.25	4.58	3.82	1.53	0.00	0.76	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	118.61	8.90	2.22	2.22	1.85	0.00	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	274.15	30.76	9.69	13.26	1.87	1.19	0.00	0.51	0.51	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	278.85	34.68	20.81	16.03	3.08	1.85	0.15	0.00	0.92	0.00
teratocarcinoma cell line:PA-1	10807-111A6	306.55	31.46	11.93	10.85	1.24	1.39	0.00	0.00	0.62	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	214.29	23.10	8.38	18.28	1.40	3.30	0.25	0.00	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	205.35	10.59	10.59	8.32	1.51	1.89	0.76	0.76	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	247.46	12.11	6.87	4.14	1.74	3.82	0.33	0.22	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	326.35	18.89	19.22	7.82	3.91	2.93	0.00	2.93	0.33	0.00
testis, adult, pool1	10026-101D8	170.62	13.64	13.85	6.33	19.76	1.93	2.47	2.47	0.54	0.32
testis, adult, pool2	10096-102C6	177.28	22.55	26.61	6.32	41.95	1.80	0.45	4.96	0.45	0.90
thalamus - adult, donor10196	10168-103B6	408.47	34.22	18.77	5.52	4.42	1.10	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	475.57	54.86	30.01	7.19	5.00	0.63	0.78	0.16	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	118.55	49.27	13.86	4.62	12.32	0.00	0.00	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	150.03	18.12	10.21	3.29	5.93	0.66	0.00	0.33	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	144.41	16.68	3.45	1.15	5.18	0.00	0.00	2.30	0.00	0.00
throat, adult	10209-103G2	239.93	23.22	13.23	4.24	4.99	2.50	4.99	0.50	0.25	0.75
throat, fetal, donor1	10061-101H7	254.73	26.81	20.72	7.62	3.05	0.91	0.61	0.00	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	334.47	40.54	22.85	11.73	13.12	0.99	0.40	0.40	0.79	0.00
thymus, adult, pool1	10027-101D9	214.74	25.85	17.00	2.88	12.13	1.19	2.29	0.40	0.99	0.89
thymus, fetal, pool1	10043-101F7	337.48	29.40	33.77	6.23	20.99	1.66	1.45	1.25	0.83	1.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	206.22	20.87	4.79	5.72	4.39	0.80	0.40	0.00	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	194.17	15.92	6.84	3.21	3.91	0.14	0.56	0.42	0.42	0.00
thyroid, adult, pool1	10028-101E1	123.92	7.56	5.04	3.55	2.61	0.75	4.29	0.56	0.19	0.09
thyroid, fetal, donor1	10060-101H6	221.74	21.09	13.45	6.86	4.48	0.26	0.53	0.53	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	495.82	46.19	24.64	3.08	15.40	9.24	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	227.00	28.84	10.47	3.72	4.19	3.02	1.40	0.00	0.23	0.00
tongue, fetal, donor1	10059-101H5	225.42	29.16	6.31	6.31	5.12	0.39	2.36	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	207.36	14.93	15.83	6.71	14.73	0.40	2.50	0.60	0.30	1.00
trachea, adult, pool1	10029-101E2	163.92	12.52	6.63	3.84	4.99	1.06	2.62	0.25	0.25	0.25
trachea, fetal, donor1	10058-101H4	245.82	16.93	14.23	3.46	4.23	0.77	0.77	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	185.29	21.61	2.48	5.67	2.48	1.06	1.06	1.06	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	253.70	32.42	10.44	8.41	6.48	2.94	2.33	0.10	0.51	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	336.41	21.00	13.79	23.03	9.24	6.74	1.72	0.47	0.78	0.00
tridermal teratoma cell line:HGRT	10694-109G1	152.20	11.42	1.90	3.81	5.71	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	131.21	13.54	4.15	4.99	1.78	0.68	0.42	0.08	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	143.97	10.43	10.43	8.35	4.17	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	260.55	25.76	14.16	3.07	3.58	0.17	0.00	0.34	0.00	0.17
uterus, fetal, donor1	10055-101H1	341.97	27.64	12.80	12.29	5.63	0.51	2.05	0.51	0.00	0.00
vagina, adult	10204-103F6	146.04	9.05	3.88	0.65	1.29	0.65	3.23	0.00	0.00	0.00
vein, adult	10191-103E2	171.63	12.06	14.03	3.29	7.01	0.88	1.97	0.66	0.00	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	173.31	12.28	9.61	3.20	2.14	0.53	0.27	0.00	0.27	0.27